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Preface 
 
 
 
My primary research interest is focused on the field of cellular electrical activity, ranging from the 
ion channels that generates it, up to the study of intracellular processes regulating it, and new 
generation of drugs. For this purpose, during my Ph.D. I have learnt and improved different 
cutting-edge techniques, i.e. the patch-clamp technique, the fluorescence imaging, and the 
synthesis and use of model membranes. Moreover, to explore particular aspects of these 
molecular mechanisms and to overcome the issues raised during the investigations, non-
conventional strategies were employed, even requiring the development of specific devices not 
commercially available. 
In summary, my Ph.D. thesis is focused on two projects: the biophysical characterization of a 
particular class of membrane active peptides, and the modulation of visual phototransduction in 
vertebrate cones.  
In the first project, I investigated the mechanism of membrane perturbation of cell-penetrating 
and antimicrobial peptides using the patch-clamp technique. Cell-penetrating peptides (CPPs) are 
short peptides that are able to cross the cell membrane via energy-dependent and/or independent 
mechanisms, with low toxicity and without the use of specific receptors (Bechara and Sagan, 
2013). This ability is preserved even when CPPs are conjugated with a large cargo, thus 
representing an innovative pharmacological tool for the diffusion of large and hydrophilic drugs 
into the cells (Stewart et al., 2008). Despite the mechanism of cellular uptake is still debated in 
literature, it has been proved that it can occur by either direct translocation (Derossi et al., 1996; 
Vivès et al., 1997) or endocytosis (Richard et al., 2003; Duchardt et al., 2007). In the latter case, 
though, the cargo-peptide complex often remains trapped inside the endocytic vesicles and is not 
able to reach its therapeutic target (Lindgren et al., 2000). A possible solution to this problem could 
be found in another class of small peptides, similar to CPPs, i.e. the antimicrobial peptides (AMPs). 
AMPs are 12-50 amino acids long peptides, which represent an essential part in the innate immune 
system in most organisms. Indeed, they are among the first defensive molecules released during 
infections and their activity is direct thorough the membrane of bacteria, causing its destruction 
and consequently the death of the pathogen (Reddy et al., 2004). Therefore, the ability of AMPs 
to disrupt biological membranes could be exploited to improve the CPPs escape from the 
endocytic vesicles in addition to, of course, their application as a novel class of antibiotics. The 
idea is to conjugate the CPP with a molecule that possess an antimicrobial activity, which can 
destroy the vesicle membrane, and help the complex to reach its target once it has been 
internalized in the cell. 
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On this ground, the first project I carried out regards the study of a novel chimeric peptide, CM18-
Tat11, composed of the antimicrobial peptide CM18 (a cecropin-mellitin hybrid peptide) linked to 
the cell-penetrating peptide Tat11 (derived from the basic domain of HIV-1 Tat protein). In 
particular, I investigated the membrane perturbing activity of this peptide (and of its elements) 
using the patch-clamp technique and operating under strictly physiological conditions. This study 
has been carried out by recording the ion current flowing through the channels formed by these 
peptides (if any), once inserted in the membrane of Chinese hamster ovary (CHO) cells. In these 
experiments, the peptides were applied to (and removed from) the extracellular CHO membrane 
in ~50 ms with a computer-controlled microperfusion system. Therefore, besides assessing ion 
channel characteristics, the dynamics of pore formation and disaggregation could be precisely 
evaluated as well. I found that CM18-Tat11 produces a large and irreversible plasma membrane 
lysis, at concentration where CM18 and Tat11 give instead a nearly reversible membrane 
permeabilization and no perturbation, respectively. Furthermore, using the same method, I 
studied the biophysical characteristic of another antimicrobial peptide, called CM12, which 
sequence was obtained from the optimization of CM18 (Maccari et al., 2013). When applied on 
CHO, CM12 and CM18 produce voltage-independent membrane permeabilization, and no single-
channel events were detected at low peptides concentration. These results indicate that both 
peptides form pores according to a toroidal model, in which the lipid layer bends continuously 
through the pore so that the core is formed by both lipid head groups and the peptides. Finally, I 
have studied the single channels properties generated by the pore-forming peptide alamethicin 
(Alm) F50/5 and its [L-Glu(OMe)7,18,19] analog inserted in a natural membrane and in giant 
unilamellar vesicles (GUVs). The possibility to compare the channel activity in the precisely 
controlled lipid environment of GUVs, with the one recorded in a natural membrane, will open 
new possibilities in the biophysical characterization of the pores. 
The second project of this thesis is focused on the study of the physiological role of the calcium 
sensor GCAP3 (guanylate cyclase activated protein 3) in the phototransduction cascade in 
zebrafish. I pursued this study simulating the over expressions and the knockdown of this protein, 
through the delivery of zGCAP3, or of its monoclonal antibody, into zebrafish cone cytoplasm, 
while recording their photorensponses with the patch-clamp technique. The proteins were 
administered inside the cone via the patch pipette thanks to an intracellular perfusion system 
developed in this thesis. This system allows the delivery of exogenous molecules inside the cell 
with a controlled timing, by expelling them with a small teflon tube inserted into the pipette lumen 
controlled by a microperfusion apparatus. Results indicated that the increase in the concentration 
in zGCAP3 did not altered significantly the light response, while the perfusion with the antibody 
anti-zGCAP3 caused the progressive fall of the dark current, together with the progressive slowing 
down of the flash response kinetics. The surprising lack of an effect of zGCAP3 incorporation, 
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suggests that the endogenous number of zGCAP3 is saturating, therefore any further increase of 
this sensor is ineffective. However, the effects of the antibody can be explained as an inhibition of 
the target enzyme of zGCAP3, which is the guanylate cyclase (GC). 
Finally, no experiments mentioned above would have been accomplished without the 
development of a “pressure-polishing” system, which makes it possible to modify the geometry of 
the patch-clamp pipette. The pipette shank (the final part of the pipette) is, in fact, very long and 
tapered, thus generating a high resistance to the passage of ions and molecules, and making very 
difficult to perfuse efficiently the cell with the internal perfusion. The pressure polishing setup I 
developed enlarged the patch pipette shank, using a calibrated combination of heat and air 
pressure. These pipettes minimized errors in membrane potential control and allowed the 
insertion of teflon tubes in the pipette lumen very close to its tip. 
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Aib    α-aminoisobutyric acid 
Alm    Alamethicin 
AMP    Antimicrobial peptide 
ATP    Adenosine triphosphate 
cGMP    Guanosine 3’,5’-cyclic adenosine monophosphate 
CHO    Chinese hamster ovary 
CM    Cecropin-melittin 
CPP    Cell-penetrating peptide 
DMEM    Dulbecco’s Modified Eagle’s Medium 
DNA    Deoxyribonucleic acid 
GC    Guanylate cyclase 
GCAP    Guanylate cyclase activating protein 
GCL    Ganglion cell layer 
GDP    Guanosine diphosphate 
GTP    Guanosine triphosphate 
GUV    Giant unilamellar vesicle 
HEPES    N-[2-hydroxyethyl]piperazine-N’-[2ethasulfonic acid] 
HIV    Human immunodeficiency virus 
Imax    Steady-state current 
INL    Inner nuclear layer 
IPL    Inner plexiform layer 
IS    Inner segment 
ITO    Indium tin oxide 
LWS    Long wavelength sensitive 
MCPP    Multivalent cell-penetrating peptide 
MWS    Medium wavelength sensitive 
ONL    Outer nuclear layer 
OPL    Outer plexiform layer 
OS    Outer segment 
pAnt    Antennapedia peptide 
PBS    Phosphate buffered saline 
PDE    Phosphodiesterase 
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Ra    Access resistance 
Rm    Membrane resistance 
Rh    Rhodopsin (inactive) 
Rh*    Rhodopsin (active) 
RPE    Retinal pigment epithelium 
siRNA    Small interfering ribonucleic acid 
SWS    Short wavelength sensitive 
τa    Activation time constant 
τd    Deactivation time constant 
Tat    Trans-activator of transcription 
UV    Ultraviolet 
Vh    Holding potential 
zGCAP    Guanylate cyclase activating protein of zebrafish 
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Part I 
Membrane Active Peptides:  
Biophysical Characterization in Natural and Model 
Membranes 
 
 
 
1.1 Cell-Penetrating Peptides 
Cell-penetrating Peptides (CPPs) are short peptides that have the ability to translocate across the 
cell membrane in a non-disruptive way, overcoming the semipermeable nature of biological 
membranes. Since their discovery, more than twenty years ago, it was clear that a deeper 
knowledge of CPPs could have been very useful in many ways. First of all, studying these peptides 
can help to shed light on the prime mechanism of cellular entry across the plasma membrane; but 
CPPs represent also an innovative tool for the delivery of different molecules inside the cells. 
Historically, the first observation that some proteins were able to pass thorough the membrane 
was made in 1988, when Frankel and Pabo were developing an assay to measure the activity of 
the Tat protein from the Human Immunodeficiency Virus 1 (HIV-1). They observed an unexpected 
result: purified Tat, a regulatory protein that trans-activate genes expressed in HIV genome, was 
taken up by cells in culture without using any loading method (Frankel and Pabo, 1988). In the 
same year, another group made the same observations (Green and Loewenstein, 1988), and both 
works were published simultaneously. Later, a new polypeptide, pAnt, was discovered, derived 
from the Antennapedia transcription factor of Drosophila melanogaster, that is able to penetrate 
neurons and regulate their morphological differentiation (Joliot et al., 1991). 
The interesting activity of these proteins, and of their transduction domain, stimulated researchers 
to find the shortest amino acid sequence necessary for the uptake. This led to the identification of 
the first CPPs: Tat peptide, that corresponds to the basic domain of HIV-1 Tat protein (Vivès et al., 
1997) and penetratin, corresponding to the third helix of the Antennapedia homeodomain 
(Derossi et al., 1994). Nowadays, several peptides showing the same penetrating activity have 
been discovered and studied, but this field of research is relatively young, and there are a lot of 
question still unanswered. In particular, the mechanism through which CPPs operates remains 
subject of controversy in the literature. Moreover, many efforts are made in order to exploit the 
ability to cross the membrane for the internalization of drugs, and more generally molecules, 
called cargoes, into the cell. In the following sections, a brief overview on CPPs will be given, firstly 
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presenting a general classification of these peptides, followed by the most accepted theories on 
the mechanism of internalization and their pharmaceutical use in drug delivery. 
 
1.1.1 Classification of CPPs 
Despite their low number of amino acids, usually less than 30, CPPs differ considerably in terms of 
composition and 3D structure. According to the physical-chemical properties of their sequences, 
it is possible to identify three main classes of CPPs: hydrophobic, amphipathic and cationic 
peptides. Most of CPPs have a net positive charge, but also anionic and neutral peptides are 
present in this large family. 
Recently, several groups have proposed a clearer overview, based not only on the primary 
sequence of the CPP, but also on the conformation arranged by the peptide when is in contact 
with the cell membrane (Fernández-Carneado et al., 2004; Deshayes et al., 2005). Here, 
amphipathic peptides are also subdivided in primary and secondary amphipathic peptides. Primary 
amphipathic peptides, such as trasportan (Pooga et al., 1998) and Pep-1 (Morris et al., 2001), 
contain typically more than 20 amino acids, and alternate hydrophobic and cationic domains in 
their primary sequence. On the other hand, peptides that exhibit their amphipathic characteristic 
only through a change in their secondary structure are called secondary amphipathic CPPs. They 
are usually smaller, and upon interaction with lipids assume the classic α-helical or β-sheet 
conformations, which allow the positioning of hydrophobic and hydrophilic residues in separate 
faces of the molecule and are essential for the penetrating activity. In this group are present 
penetratin (Derossi et al., 1996), proline-rich CPPs, and the model amphipathic peptide (Oehlke et 
al., 1998). Finally, there are non-amphipathic CPPs whose sequence is very hydrophobic or 
presents mostly cationic amino acid. This class includes Tat peptide (Vivès et al., 1997) and 
polyarginine peptides (e.g. R9) (Futaki et al., 2001; Tünnemann et al., 2008), and they do not 
require a specific 3D-structure for uptake (Eiríksdóttir et al., 2010). 
Another simple classification is based on the origin of the peptide (Table 1.1), and in this case we 
can distinguish protein-derived peptides, chimeric peptides (formed by the fusion of two natural 
sequences), and synthetic peptides rationally designed starting from natural sequences (especially 
antimicrobial peptides). 
 
1.1.2 Mechanism of Action of CPPs 
A common feature of CPPs is that they are able to penetrate the cell membrane at low micromolar 
concentrations, both in vivo and in vitro, with very low toxicity (Mäe and Langel, 2006; Järver et 
al., 2010). However, as previously mentioned, in literature there is no consensus about the 
mechanism of cellular internalization. Of course, the wide structural diversity among these 
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peptides results in different modes and levels of uptake, but also the type of cargo carried by the 
CPPs, cell type, and the experimental conditions can affect profoundly their uptake mechanism. 
The first studies on penetratin, Tat, and R9 indicated that the internalization of these peptides is 
receptor-independent and not significantly suppressed by depletion of the intracellular ATP, by 
inhibitors of endocytosis, or by low temperatures (Derossi et al., 1996; Vivès et al., 1997; Futaki et 
al., 2001; Suzuki et al., 2002). Based on these results, it was commonly accepted that these 
peptides were entering the cells via direct translocation through the membrane lipid bilayer. Not 
long after, though, Lebleu and colleagues discovered that most of the methods used in those 
experiment, especially the cell fixation with methanol prior to fluorescence assays, led to 
artifactual results (Richard et al., 2003). In this way, they re-evaluated the mechanism of uptake 
based on endocytosis and, from then, the research was mainly directed on that field. 
Pharmacologically, in fact, endocytosis is the most interesting mechanism of internalization, since 
applications of CPPs focused on import of macromolecular cargo, and endocytosis is the preferred 
route for cargo uptake (Tünnemann et al., 2006). Nowadays, both energy-independent 
translocation and endocytosis are commonly accepted, even for the same CPP, with the latter 
believed to be the most common mechanism at low peptide concentrations (Holm and Langel, 
2005; Nakase et al., 2009). 
Direct Translocation 
Direct translocation via energy-independent mechanisms may include different pathways such as 
inverted micelle formation (Derossi et al., 1996), pore formation (Herce et al., 2009), carpet-like 
perturbation (Piantavigna et al., 2011), and the 
membrane thinning model (Herce and Garcia, 
2007). In any case, the first step in all these 
mechanisms is the interaction of the CPP’s positive 
charge with the membrane components that are 
negatively charged. The subsequent destabilization 
of the membrane is often associated with peptide 
folding, and vary a lot depending on the peptide 
sequence and concentration, as well as the 
lipid/protein composition of the membrane.  
In the “inverted micelle” model (Figure 1.1), initially 
proposed for pAnt (Berlose et al., 1996), the 
interaction of the peptides with the membrane 
slightly disrupts the lipid bilayer, leading to the 
formation of hexagonal structures (inverted 
Figure 1.1 Inverted micelle formation 
(modified from Bechara and Sagan, 2013). 
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micelles). The CPPs remain confined in the hydrophilic core of the micelles, until the inverse 
process occurs and the peptides are released in the intracellular environment.  
However, given the limited space inside the micelles, this mechanism is not likely to occur for 
macromolecular complexes (e.g. CPP-cargo conjugates), but admits only the uptake of small 
hydrophilic peptides. The “pore formation” and the “carpet-like” model are analogue to those 
mechanisms of membrane perturbation used to explain the activity of AMPs, and will be further 
described in detail in this thesis (see Mechanisms of Action of AMPs). 
Finally, since direct translocation occurs only when the CPPs reach a threshold concentration on 
the membrane, all these mechanisms requires the cell membrane to face high concentration of 
the peptides and extensive destabilization. These results are in conflict with the features of many 
CPPs, i.e. low cytotoxicity and low-concentration efficacy; therefore, none of the models described 
above can give a complete explanation of the data experimentally obtained, suggesting that 
alternative pathways should participate in peptide translocation. 
Endocytosis 
Endocytosis is an energy-dependent process that triggers the uptake of molecules (or even other 
cells) of different type and weight (Conner and Schmid, 2003). This is not a single mechanism; in 
fact, two different pathways can be recognized: phagocytosis and pinocytosis. The first one occurs 
only in specialized cells (e.g. macrophages) and, of course, is not involved in CPPs mechanism of 
action. On the contrary, pinocytosis is common among many eukaryotic cells and seems to play an 
important role in the internalization of CPPs, especially when they are conjugated with large 
cargoes (Lundin et al., 2008). There are four basic modes of pinocytosis: macropinocytosis, 
clathrin-dependent endocytosis (CDE), endocytosis mediated by caveolae, and clathrin and 
caveolae-independent endocytosis (Figure 1.2). Macropinocytosis is a non-specific process that 
leads to the formation of large vesicles, called macropinosomes (> 1 µm), generated by a 
membrane ruffling that surrounds and gradually internalizes part of the extracellular fluid and all 
the molecules dissolved inside it (Swanson and Watts, 1995). In CDE, the formation of the vesicle 
is preceded by the interaction of a ligand with specific transmembrane receptors, which cause 
invagination of a clathrin-coated piece of membrane. A receptor binding is also required in the 
endocytosis mediated by caveolae, but while the clathrin-coated vesicles are about 120 nm in 
diameter, caveolin-coated do not exceed 50-60 nm (Mayor and Pagano, 2007). Finally, clathrin 
and caveolae-independent endocytosis group several mechanisms that are related to the 
internalization of microdomains present on the cell surface, called ‘rafts’ (Conner and Schmid, 
2003). 
It is now evident that CPPs do not enter the cells via a single favorite method; indeed, the 
mechanism used strongly depends on their attached cargo (Maiolo et al., 2005). For instance, Tat 
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peptide uses a clathrin and caveole-independent endocytosis when conjugated to a protein 
(Fittipaldi et al., 2003), but clathrin-dependent endocytosis when conjugated to a fluorophore 
(Richard et al., 2005). Furthermore, it is important to emphasize that all endocytic processes end 
with the enclosure of the CPP and its linked cargo into lipid vesicles, where they can remain for 
extended periods of time and undergo degradation. In order to exploit CPPs for clinical 
applications, an efficient vesicular escape is therefore needed. At the present, several studies have 
the primary goal to overcome this problem, and some of them will be introduced in the next 
section, dedicated to the therapeutic applications of CPPs. 
 
Figure 1.2 Different endocytic pathways. Phagocytosis is limited to specialized cells (e.g. macrophages); 
CPPs can enter the cells by using all pinocytosis mechanisms (Conner and Schmid, 2003). 
 
1.1.3 Applications in Drug Delivery 
As mentioned before, the ability of CPPs to translocate across the cellular membrane represents 
a major breakthrough for the introduction of drugs and large molecules into the cells for 
therapeutic purposes. At the moment, we are witnessing a dramatic acceleration in the 
development of novel therapeutic molecules such as proteins, peptides, nanoparticles and 
numerous nucleic acids: oligonucleotides, small interfering RNA (siRNA), plasmid and viral genes. 
Unfortunately, due to their physicochemical properties, these compounds exhibit several issues 
like poor stability in vivo and lack of cellular uptake and specificity. Therefore, the optimization of 
their intracellular delivery is one of the major priorities, and CPPs seems to be excellent candidates 
for this goal, offering several advantages over other tested vectors like liposomes or nanotubes 
(Veldhoen et al., 2006; Cirillo et al., 2014; Mallick and Choi, 2014). 
Indeed, many studies present promising results in CPP-mediated intracellular delivery of many 
drugs, both in vitro and in vivo, including antisense oligonucleotides (Astriab-Fisher et al., 2002), 
antibodies (Morris et al., 2001), peptides and proteins (Snyder and Dowdy, 2005; Gros et al., 2006), 
and even contrast agents for in vivo imaging (Kersemans et al., 2008). The most representative 
applications of CPPs are reported in Table 1.1. 
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Table 1.1 
Most representative CPPs: origins and applications. 
CPP Origin Cargo types 
Protein-derived   
Tat11 HIV-Tat protein (48-58) protein/peptide/siRNA/liposome/nanoparticles 
Penetratin Antennapedia (43-58) peptide/siRNA/liposome 
Chimeric-peptides   
Pep-1 Trp-rich motif/SV40 T-antigen protein/peptide 
MPG HIV-gp41/SV40 T-antigen siRNA/ODN/plasmid 
Transportan Galanin/Mastoparan protein/PNA/siRNA 
Synthetic-peptides   
Polyarginine Based on Tat peptide protein/peptide/siRNa/ODN 
MAP  small molecule/plasmid  
 ODN, oligodeoxynucleotide; PNA, peptide-nucleic acid. 
 
Covalent or Non-Covalent? 
Among the numerous attempts in using CPPs as drug carriers, we can distinguish two principal 
strategies. The first one is the covalent strategy, which requires the formation of a covalent bond 
between the CPP and the cargo, achieved by either chemical cross-linking (Zorko and Langel, 2005; 
Lundin et al., 2008) or by cloning and expression of recombinant conjugates (Münst et al., 2009; 
Heffernan et al., 2012). Despite all the advantages offered by covalent technology (high 
reproducibility and stoichiometry control), the synthetic covalent bond can alter the biological 
activity of the cargo, thus resulting in a loss of its function. This problem especially concern siRNA 
and oligonucleotides conjugates (Meade and Dowdy, 2007; Juliano et al., 2008), for which non-
covalent strategies appear to be a better solution (Simeoni et al., 2003). In this case, in fact, the 
cargo molecules do not undergo any chemical modifications, since they are associated with the 
CPPs only through electrostatic and hydrophobic interactions (Morris et al., 2001; Simeoni et al., 
2003; Gros et al., 2006). 
Overcoming Endosomal Entrapment 
In order to exert its pharmacological activity, it is important for the cargo to reach its specific 
target. To ensure this, the passage through the cellular membrane is not the only limiting step. 
Indeed, CPP-cargo conjugates that enter the cell following one of the endocytic pathways are often 
sequestered into vesicles, keeping them from reaching their intracellular target. In addition, along 
with the endosomal membrane barrier, trapped macromolecules have to face a pH decrease and 
the attack by hydrolytic enzymes (Lee et al., 2008). 
In recent years, many research groups proposed several solution to enhance endosomal escape 
(Erazo-Oliveras et al., 2012). One approach suggests the use of multivalent CPPs (MCPPs), which 
consist of creating an oligomer with multiple copies of the same CPP, in order to increase its local 
concentration when it interacts with membranes (Kawamura et al., 2006; Hassane et al., 2009). 
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MCPPs can be obtained by attaching two or more CPP monomers with protein highly branched 
molecules (Juliano et al., 2008), scaffolds (Sheldon et al., 1995) or simple disulphide bridges 
(Rudolph et al., 2004). Despite their encouraging increase in activity, the complex and expensive 
methods for the synthesis of MCPPs is an important limitation. Moreover, it is possible that similar 
compounds could act as immunogens, producing an unpleasant immune response (Schwarze et 
al., 1999). 
Another approach that has been proposed to increase endosomal escape is based on the addition 
of chromophores that, upon activation with an appropriate light stimulus, are able to disrupt the 
vesicle membrane. Here, CPPs are linked to fluorophores (Maiolo et al., 2004) as well as to 
photosensitizers (Choi et al., 2006; Zhao et al., 2011), but in several experiments a significant 
phototoxic activity is observed, causing cell damage and apoptosis (Choi et al., 2006; Oliveira et 
al., 2007). 
The endosomal entrapment of CPP-cargo complexes can be overcome also with the help of other 
specific peptides. For instance, pH-dependent membrane-active peptides (PMAPs) are pH-
sensitive peptides that become active only in acid environment (El-Sayed et al., 2009). This activity 
is extremely advantageous in this context, since the pH in the endosome lumen gradually drops as 
maturation occurs (Schmid et al., 1989; Serresi et al., 2009). An example of PMAP is the HA2 fusion 
peptide, which has been proved to increase endosomal escape of several cargoes when associated 
with CPPs such as Tat peptide (Kumar et al., 2007; Lee et al., 2011) and penetratin (Lundberg et 
al., 2007). Another class of peptides that received researchers’ attention is the antimicrobial 
peptides (AMPs) family. These small peptides possess membrane-perturbing activity (see Section 
1.2, dedicated to AMPs); therefore, they might be able to permeabilize the endosome membrane 
leading to the release of its contents. 
The work of this thesis is in part dedicated to the study of an AMP-CPP hybrid, called CM18-Tat11, 
synthetized by the group of prof. Beltram of NEST laboratory (Scuola Normale Superiore and 
Istituto Nanoscienze-CNR, Pisa): the characteristics of this novel peptide will be described in details 
in Section 1.3.1. 
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1.2 Antimicrobial Peptides 
The first discovery of substances that possess antimicrobial activity dates back to the first half of 
the nineteenth century, when many compounds isolated from normal tissues and body fluids were 
found to kill both Gram-positive and Gram-negative bacteria (Skarnes and Watson, 1957). 
Nowadays, we know that those molecules are evolutionally conserved oligopeptides that play an 
important role in the innate immune response. To date, the antimicrobial peptide (AMP) database 
contains 2480 peptides (http://aps.unmc.edu/AP/main.html, last update: Dec 2014) which have 
been identified in several species ranging from bacteria to mammals, including humans and plants 
(Wang and Wang, 2004). 
AMPs are typically short sequences (between 12 and 50 amino acids), with a net positive charge 
that range from +2 to +9. In addition to their broad spectrum activity against both Gram-positive 
and Gram-negative bacteria, some AMPs are also lethal for parasites, fungi, yeasts, and viruses 
(Zasloff, 2002). Furthermore, a promising anti-tumorigenic activity of some AMPs has also been 
observed (Papo and Shai, 2005; Hoskin and Ramamoorthy, 2008; Schweizer, 2009). Some early 
observations also suggest that AMP function is not exclusively limited to innate immunity. Some 
peptides, e.g. defensins, seem to modulate angiogenesis, promote inflammatory response and 
stimulate adaptive immune system by inducing cytokine secretions, recruiting dendritic cells and 
macrophages (Suarez-Carmona et al., 2014). All these properties make AMPs a promising resource 
in the development of new drugs, not only as new antibiotics, but also against tumors and many 
other diseases (Reddy et al., 2004). 
The mechanism of action used by several AMPs in their antimicrobial activity is based on the 
formation of transmembrane pores on the bacterial membrane, altering its permeability and 
leading to bacteria’s death (Figure 1.3). For this reason, and given their evolutionary conserved 
sequences, AMPs provide a simple model in understanding the molecular basis of peptide-lipid 
interactions in membranes, as well as the structure-function relationships of ion channels, ion 
pumps and exchangers (Marsh, 1996). A better knowledge of such mechanisms could then be 
exploited to build custom molecules with a wide range of applications in biotechnology, like ion 
channel modulators (Hille, 2001), biosensors for several analytes (Aili and Stevens, 2010), and may 
provide also a pharmacological approach for the treatment of channelopathies (Wilde, 2008). In 
the latter case, a synthetic channel could incorporated in cells expressing an aberrant ion channel 
and restore the physiological ion flow. Encouraging results have been obtained in human epithelia 
of the cystic fibrosis patients with a defective chloride channel (Wallace et al., 2000). 
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1.2.1 Classification of AMPs 
As for CPPs, AMPs can also be classified in different ways according to their origin, amino acid 
sequence and structure. From a structural point of view, we can distinguish two major groups: α-
helical peptides and β-sheet peptides. The first group includes cecropins (the first AMP identified) 
and magainins, and more in general linear cationic peptides, with less than 40 amino acids, that 
lack cysteine residues (Brogden, 2005). They are disordered in aqueous solutions, but have the 
tendency to form highly amphipathic helix in organic solvents and lipid vesicles (Marion et al., 
1988; Bechinger, 1999). In this case, the folded peptide exhibits its hydrophilic amino acids 
residues along one side of the helix and its hydrophobic amino acids residues along the opposite 
side, thus allowing the contact with both the lipids and the aqueous environment. In the second 
group are present anionic and cationic AMPs with cysteine in their sequence and form one or more 
disulfide bridge that maintain the β-sheet structure of the peptide (Dhople et al., 2006). The most 
representative AMPs in this group are defensins, derived from humans and several mammals, and 
protegrin. Other peptides not included in this simple classification are cyclic AMPs and cationic 
peptides enriched for specific amino acids like proline, arginine or tryptophan (Reddy et al., 2004). 
 
Figure 1.3 Scanning electron microscopy of two different bacterial strains untreated (control), 
and treated with AMPs (+ AMP). Upon peptide interaction, bacterial membranes appear 
corrugated and show small protruding blebs (arrows) (modified from Bi et al., 2014). 
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1.2.2 Mechanisms of Action of AMPs 
In literature, two different strategies are proposed for the antimicrobial activity of AMPs. The most 
validate mechanism is the previously mentioned formation of transmembrane pore, which cause 
an extensive membrane rupture leading to the lysis and death of the microbial cells. However, 
recent studies revealed that AMPs might have also intracellular targets, including DNA, RNA, and 
protein synthesis, as well as enzymatic processes essential for bacteria metabolism (Lee and Lee, 
2014; Choi et al., 2015). These mechanisms are not fully understand yet, thus more researches are 
required on this argument. On the other hand, the membrane-disrupting activity of AMPs has 
been deeply investigated in the last years. By now, there are three main models able to describe 
the AMPs modes of membrane perturbation (Figure 1.4): “barrel-stave”, “toroidal” and “carpet” 
model (Brogden, 2005). 
Barrel-stave Model 
In the barrel-stave model, the peptides initially bind in parallel on the membrane surface due to 
an electrostatic interaction (Figure 1.4 A). As the peptide monomers accumulates on the 
membrane, they insert perpendicularly in the membrane and bind together around a central pore, 
arranging like the staves of a barrel (Figure 1.4 B). In this structure, the peptide helices are 
organized in a way that the hydrophobic residues interact with the lipid core of the membrane, 
while the hydrophilic segments face the aqueous lumen of the pore. According to this mechanism, 
when a peptide monomer inserts in the bilayer, it recruits other peptides to form the aggregates, 
acting in a cooperative way. One of the most representative peptide acting with this mechanism 
is alamethicin (Baumann and Mueller, 1974).  
Toroidal Model 
The toroidal pore differs from the barrel-stave one in that the peptide monomers do not aggregate 
with each other, but rather interact with the polar head groups of the lipids, even when the 
peptides are arranged vertically in the membrane. The interaction between the peptides and the 
phospholipid head groups is stronger than in the case of the barrel-stave model, so that the lipid 
monolayer is forced to bend back on itself, connecting one side to the other of the membrane, in 
a toroidal shape manner. Therefore, the pore walls are formed by lipids and peptides, and not by 
peptides only as in the barrel-stave model (Figure 1.4 C). This particular model was first proposed 
to describe the pores formed by the peptide magainin (Ludtke et al., 1996; Matsuzaki et al., 1996). 
Carpet Model 
In the carpet mechanism, the strong electrostatic interaction between the peptides and the 
phospholipid head groups leads to a peptide-induce membrane ‘carpeting’ effect. Once the 
peptides have reach a threshold concentration on the membrane, they assemble to form 
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transiently toroidal pores, allowing more and more peptides to cross the membrane and 
eventually cover the other membrane leaflet, so that the bilayer is rapidly and extremely 
perturbed and disintegrated. It is also possible that entire fragments of the membrane, called 
micelles, are detached from the membrane itself in a detergent-like manner (Figure 1.4 D). 
Of course, similarly to the case of CPPs, the same AMP do not act following exclusively one of the 
models described above. Indeed, it has been demonstrated that temperature, peptide 
concentration, the presence of metal ions and other environmental conditions might change the 
activity of the same AMP from one mechanism of action to another (Brogden, 2005; Noshiro et 
al., 2010). 
 
 
 
1.2.3 AMPs vs Multidrug-Resistant Bacteria 
Since the discovery of penicillin, antibiotics are considered one of the major discoveries of modern 
medicine. Unfortunately, the dramatic increase in antibiotic-resistant bacterial strains causes a 
loss of efficacy of these broadly used drugs, with negative consequences in the healthcare system 
along with social and economic implications (Huttner et al., 2013; Rossolini et al., 2014). 
Furthermore, the multidrug-resistant infections that in the past years were limited to hospital or 
large communities, are now spreading all over the world. Thus, innovative strategies for the 
development of new treatments are urgently needed. 
Among all the ongoing attempts to find a solution to the so called “antibiotic resistance crisis”, 
AMPs represent an encouraging resource for future drug development. The reason is that all the 
strategies developed by microorganisms in order to overwhelm antibiotics are entirely 
intracellular mechanisms: 1) alteration of the antibiotic target (Wilson, 2014); 2) antibiotic 
Figure 1.4 Mechanisms of peptide-induced membrane permeabilization. After adhering on the external 
face of the membrane (A), the peptide could insert in the membrane according to a barrel stave (B), 
toroidal (C), or carpet mechanism (D). 
 
 
 
 
13 
  
degradation by specific enzymes (Wright, 2005); 3) antibiotic expulsion thorough membrane 
pumps (Li and Nikaido, 2004). On the other hand, the effect of the AMPs against the bacterial 
membrane is driven by an aspecific interaction with the peptides and the double layer. Since 
modifications in the physical structure of the membrane are very difficult to occur, the 
development of an AMP resistance is very unlikely.  
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1.3  Aim of This Work (pt. I):  
Mechanism of Action of Membrane Active Peptides 
In literature, several strategies are described to assess the mechanism of AMPs activity. A simple 
and direct method is the observation via microscopy techniques of the microbial cell integrity after 
the application of AMPs (Kalfa et al., 2001; Yenugu et al., 2004). To study the biophysical 
interactions between peptides and membrane, a large variety of techniques are also employed, 
such as nuclear magnetic resonance, surface plasmon resonance (Aquila et al., 2013), circular 
dichroism and electron paramagnetic spectroscopy (Pistolesi et al., 2007). The long-term goal of 
these researches is the investigation at a molecular level of the lipid-peptide interaction, from 
orientation to conformational changes. Moreover, since pore formation is the AMPs favorite 
mechanism of action, a widely used experiment to assess their membrane permeabilization is the 
measure of the leakage of a fluorescent molecule previously confined into phospholipid vesicles 
(Orioni et al., 2009). However, none of these studies addresses directly the problem of the kinetics 
of pore formation when peptides assemble on the plasma membrane of a living cell. 
The dynamics of the formation of the AMP pore and its biophysical characteristics are investigated 
in this thesis under strict physiological conditions. For this purpose, the peptides are applied on 
the membrane of a living cell, and the ionic current that flows through the pore formed by these 
peptides is simultaneously recorded by using the patch-clamp technique (described in Materials 
and Methods). The first part of my Ph.D. work was focused on membrane active peptides is 
dedicated to the biophysical study of the mechanism of membrane perturbation of two peptides: 
the novel chimeric peptide CM18-Tat11 (and its isolated parts) and the rational designed AMP CM12. 
1.3.1 CM18-Tat11: a Chimeric CPP with Membrane-Disruptive Properties 
The arginine-rich Tat peptide (Tat11, residues 47-57 of HIV-1 Tat protein) is able to stimulate an 
efficient endocytosis of a large variety of cargoes into a wide range of target cells (Brooks et al., 
2005). These properties, plus the low toxicity for eukaryotic cells, make this peptide an excellent 
resource in drug delivery. Unfortunately, all reports show that molecules taken up by Tat11-
mediated endocytosis undergo endosomal entrapment, limiting their intracellular availability. To 
overcome this problem, it was proposed to link Tat11 with a sequence that possess membrane-
disruptive properties. An attempt was made with the fusogenic peptide HA2, derived from the 
influenza-virus hemagglutinin protein (Skehel et al., 2001). In this case, despite a slight 
enhancement of endosomal entrapment was observed (Wadia et al., 2004), still more than 99% 
of the Tat-cargo complexes remains sequestered into vesicles (Kaplan et al., 2005). 
Another resource of molecules that are able to disrupt the phospholipid barrier comes from the 
AMPs. In this thesis, the biophysical characteristics of a novel hybrid peptide formed by the CPP 
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Tat11 and the hybrid AMP, called CM18, are studied. Among all the AMPs included in this large class 
of peptides, Cecropin-A/Melittin (CM) hybrids raised particular interest because they are among 
the shortest and most effective peptides with membrane-permeabilization properties. Cecropin-
A is a linear, naturally occurring, cationic peptide initially isolated from the hemolymph of the silk 
moth Hyalophora cecropia (Steiner et al., 1981). Its 37 amino acids sequence can be divided in two 
segments: a cationic, amphipathic N-terminal domain and a hydrophobic C-terminal domain. 
Cecropin has shown to be active against both Gram-negative and Gram-positive bacteria, as well 
as against some fungi and tumor cell lines (Andreu et al., 1985). Moreover, cecropin-A possess a 
relatively slight hemolytic activity and exhibit low toxicity toward normal eukaryotic cells (Boman 
et al., 1989; Wade et al., 1992). Melittin, in contrast, is extremely hemolytic and has a stronger, 
broad-spectrum antimicrobial activity. This 26-residue peptide is isolated from the venom of the 
honey bee Apis mellifera, and contains, as cecropin-A, two distinct cationic and hydrophobic 
domains but in reverse order (Boman et al., 1989; Andreu et al., 1992). The cecropin-melittin 
hybrid are constructed combining different domains of these two peptides, with the intent to find 
the shortest sequence that display a remarkable antimicrobial activity, yet lacking the melittin-
associated hemolytic properties. In particular, CM18 hybrid (sequence: KWKLFKKIGAVLKVLTTG) is 
synthesized by combining the first seven residues of cecropin-A with residues 2-12 of melittin. 
Despite the recent results that indicate an efficient uptake and endosomal escape of cargoes 
associated with the chimeric CM18-Tat11 (Salomone et al., 2012), its mechanisms of membrane 
permeabilization are still unknown. In this thesis, a biophysical characterization of the membrane 
activity of CM18-Tat11 and its isolated domains is given, providing some suggestions about their 
mechanism of action. 
1.3.2 The Rational Designed Peptide CM12 
Despite their promising properties, the use of some natural AMPs for therapeutic applications 
turned out to be problematic, especially due to their high toxicity and vulnerability to proteolytic 
enzymes (Aoki and Ueda, 2013). For this reason, in recent years several AMP sequences have been 
improved thanks to a computer-aided optimization (Fjell et al., 2012). Along with the 
enhancement of the activity of preexisting peptides, the computational approach is exploited also 
for the identification and design of new sequences that possess an antimicrobial activity and at 
the same time lack all the unfavorable properties of natural peptides (Kaltofen et al., 2014; Maccari 
et al., 2015). Part of this thesis work is dedicated to the study of the mechanism of action of a 
rational designed AMP, called CM12, selected and synthetized by Maccari at the Center of 
Nanotechnology Innovation of NEST, in Pisa (Maccari et al., 2013). 
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1.3.3 Alamethicin F50/5 and its Analogue [L- Glu(OMe)7,18,19] 
Alamethicins (Alm) are a family of pore-forming peptides produced by the fungus Trichoderma 
viride (Meyer and Reusser, 1967; Reusser, 1967). Since their sequences contain the non-
proteogenic amino acid α-aminoisobutyric acid (Aib), they are called peptaibolic peptides. 
Alamethicins exhibit broad biological activities, including antibacterial effects against both Gram-
positive and Gram-negative bacteria (Meyer and Reusser, 1967; Jen et al., 1987; Béven et al., 
1998). It was demonstrated that these peptides are able to form voltage-dependent pores into 
biological membranes (Fox and Richards, 1982); and different mechanisms of pore formation were 
proposed to describe alamethicin mode of action. Currently, the most accepted one is the barrel-
stave model, firstly proposed by Fox and Richards (Fox and Richards, 1982; Mathew and Balaram, 
1983). 
Part of this thesis work is focused on the study of the single channel properties formed in natural 
and model membranes by the synthesized Alm F50/5 peptaibol, which is the major component of 
the neutral fraction of the alamethicin, and its synthetic analog [L- Glu(OMe)7,18,19]. The latter 
peptide was obtained by substitution of specific amino acids from the primary sequence of Alm 
F50/5. Specifically, glutamine residues at positions 7, 18, and 19 have been replaced with side-
chain esterified glutamic acid residues, since glutamine was found to play a major role in pore 
formation (Fox and Richards, 1982; Molle et al., 1996). Both peptides were inserted in a cell plasma 
membrane (of the rod outer segment of the frog retina, recorded in whole-cell) and in membrane-
patches excised from giant unilamellar vesicles (GUVs). The possibility to compare the channel 
activity in the precisely controlled lipid environment of GUVs, with the channel activity recorded 
in a natural membrane with the same ionic electrochemical gradients, will open new possibilities 
in the biophysical characterization of the pores. 
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Part II 
Real-Time Modulation of zGCAP in Zebrafish Green Cones 
 
 
 
1.4 Visual Perception 
Light perception is one of the most important environmental stimuli for all organisms. Other than 
being fundamental for the generation and preservation of life on Earth, light is, in most animal, 
the responsible of many physiological functions including circadian rhythms, defense, food-
hunting and other important behavioral reactions. Even though simple life form as Protozoa are 
sensible to light stimuli, the first draft of the vision function occurred in animals only with the 
appearance of particular photosensitive cells: the photoreceptors. Initially spread all over the body 
surface, as in many Invertebrates nowadays, the photoreceptors organized later in small 
formations called ocelli, which represent the first form of a specialized structure dedicated to 
vision. A crucial step in evolution that allowed the transition from the simple detection of light to 
real vision is the development of the eye. This organ is composed of transparent accessory 
structures, with converging lens characteristics, which allow the detection of a highly detailed final 
image. The image (real, reduced, and inverted) is focused on a layer of neuronal cells, including 
photoreceptors, arranged like a mosaic to form the retina. Here, the photoreceptors, and other 
retinal neurons connected with them, translate the light signal into an electrical signal that travel 
to the brain via axons in the optic nerve (for a complete review, see Masland, 2012). 
1.5 Retina 
The retina is a thin layer of cells lining the inner surface of the optic bulb (Figure 1.5A), and it is 
actually considered a part of the central nervous system. On the inner side of the eye, the retina 
is in direct contact with the vitreous humor, while on the other side lies in front of the retinal 
pigment epithelium (RPE) and the underlying choroid. The RPE is a layer composed of cells that 
synthetize melanin, a black pigment that captures all the light not absorbed by the retina. This 
prevents the backscattering of the light towards the receptors and avoids any image detriment.  
All vertebrate retinae are composed of five types of neurons: photoreceptors, bipolar cells, 
ganglion cells, horizontal cells, and amacrine cells. The cell bodies and their processes (long 
branches that arise from the cell body) are organized in distinct layers, clearly visible at a 
microscopic examination of a vertical section of the retina (Figure 1.5B) (Cajal, 1893; Dowling and 
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Boycott, 1966). The cell bodies of the photoreceptors are contained in the outer nuclear layer 
(ONL) while in the inner nuclear layer (INL) there are cell bodies of the bipolar, horizontal and 
amacrine cells. Ganglion cells bodies are located in the ganglion cell layer (GCL), where also some 
displaced amacrine cells can be found (Dowling, 1970). In other two different layers, called inner 
plexiform and outer plexiform layers (IPL and OPL, respectively), are positioned the neuron 
processes, and these are the areas where synaptic contacts between cells occur. Contrary to what 
can be expected, photoreceptors are not facing directly the interior of the eye, but lie in the 
deepest layer against the RPE. As a result, light must pass through the other non-light-sensitive 
layers of cells as well as the retina vasculature before reaching the photoreceptors. The reason for 
this counterintuitive organization of the retina lies in the special relationship that exist among the 
photoreceptors and the RPE. Other than absorbing the excess light, RPE is also essential for the 
preservation and turnover of photoreceptors and for the restoration of the light-sensitive 
molecules after they have been exposed to light (Young, 1967, 1971; Bok and Young, 1972; 
Anderson et al., 1978). 
 
 
Figure 1.5 Structure of the retina and photoreceptor cell types. (A) Eye picture; (B) Cross section of the retina 
(400x), PH: photoreceptors layer, ONL: outer nuclear layer, OPL: outer plexiform layer, INL: inner nuclear 
layer, IPL: inner plexiform layer, GCL, ganglion cell layer; (C) Rod and cone structure. 
 
1.5.1 Functional Architecture of Photoreceptors 
Photoreceptors are a class of highly specialized cells responsible for the transformation of a light 
stimulus into an electrical stimulus, which can reach the brain through the optic nerve. There are 
two basic types of photoreceptors, distinguished by shape: rods and cones (Figure 1.5C). In 
addition to their different morphology, they also carry out different vision functions (better 
explained in the following paragraphs); nonetheless, they share several characteristics. Both rods 
and cones have an outer segment (OS), slim rod-shaped for the former, and robust conical-shaped 
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for the latter, separated from the inner segment (IS) by a thin cilium (Anderson and Fisher, 1976). 
Notably, the OS of both types of photoreceptors are entirely filled with a succession of hundreds 
of flattened discs, disposed one on the other, that originate from invaginations of the plasma 
membrane (Cohen, 1960, 1964; Besharse and Pfenninger, 1980). The discs are continuously 
produced from the base of the OS, in the region of the cilium, and while in cones they remain 
attached to one side of the OS membrane, they completely separate in rods, becoming free-
floating discs inside the OS membrane (Steinberg et al., 1980). In these membrane discs are 
embedded many (thousands) of photosensitive molecules, also called photopigments, which are 
different in rods and cones, and consists of two parts: a protein called opsin and a chromophore, 
called retinal (Bowmaker et al., 1978; Bowmaker and Dartnall, 1980). The opsin molecule is 
synthetized in the IS and binds to the membrane discs at the cilium, whereas the retinal (derived 
from the vitamin A) is synthetized in the RPE and delivered to the discs via specific carrier 
molecules (Adler and Martin, 1982; Chader, 1989). The IS is almost entirely occupied with 
mitochondria, and contains also ribosomes and other cytoplasmic organelles, except for the 
nucleus that takes place below the IS, in the cell body. Finally, at the lower extremity of the 
photoreceptor there is an enlargement of the membrane, rich in synaptic vesicles, that forms 
synapse in contact with second order neurons. 
Rods and Dim-Light Vision 
The rods are photoreceptor cells that contain only one type of visual pigment, rhodopsin. They are 
extremely sensitive, up to the single-photon level, with a peak at ~500 nm (Brown and Wald, 1964) 
and are therefore responsible for scotopic vision, i.e. in dim light conditions, as at night. In order 
to maximize quantum catch, a very high number of visual pigments is needed, thus explaining the 
dense packing of the discs in the rod OS. Nevertheless, the price for this high is the much slower 
photoresponse compared with the one of cones (Baylor, 1987), a poor resolution of the image and 
no perception of colors (MacLeod, 1972). As a result, rod function provides vision at light 
conditions even below the level of starlight, but uncolored and with very low spatial resolution. 
Cones: Acuity and Color Vision 
As illumination increases, the participation of cones in the vision function become more and more 
important. The cone system is in fact responsible for the perception of higher intensities of light, 
the so-called photopic vision, and also possess a high spatial resolution due to the high cone 
density that provides a better visual acuity. Furthermore, cones are responsible for color 
perception, and can be divided in different classes depending on the type of opsin (the visual 
pigment of cones) they express. Each of these opsins differ from the others in the sensitivity to 
light of different wavelengths, and for this reason are referred to as short, medium, and long 
wavelength sensitive cones (SWS, MWS, and LWS, respectively). More precisely, SWS-cones are 
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known to peak around 420 nm (blue region of the spectra), MWS-cones peak around 530 nm 
(green), while LWS-cones are maximally sensitive to wavelength of about 560 nm (red) (Bowmaker 
and Dartnall, 1980; Bowmaker et al., 1980). Cones are therefore known as blue-, green-, and red-
sensitive cones and it has been shown that are morphologically different from each other, allowing 
their identification simply by optical microscopy (Sherry et al., 1998). Even though the most 
notorious color identification is based on trichromatic vision (as in humans), most mammalian 
species are merely dichromatic, while many other vertebrates are tetrachromatic, as they possess 
a fourth type of cone sensitive to ultraviolet light (UV-cones) (Bowmaker et al., 1980; Branchek 
and Bremiller, 1984). UV-cones were found among several species of reptiles (Liebman and 
Granda, 1971), amphibians (Sherry et al., 1998), birds (Bowmaker, 1980), and fishes, including 
zebrafish (Robinson et al., 1993). 
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1.6 Phototransduction 
Despite the different physiological function of rods and cones (because of their different 
morphology, response times, wavelength sensitivity, and adaptation mechanism), several 
phototransduction proteins are similar, or even the same, in any type of photoreceptors. Indeed, 
it has been proved that they evolve from common ancestors (Hisatomi and Tokunaga, 2002). For 
this reason, the cascade of intracellular events following light absorption by the visual pigments, 
named phototransduction, is comparable in all vertebrates (Lamb, 2013). Contrary to what 
happens in most sensory systems, the stimulation of a photoreceptor do not elicit action 
potentials; rather, light absorption causes only a graded change in membrane potential, 
corresponding in a change in the rate of neurotransmitter release onto postsynaptic neurons. 
Another surprising element is that the light-induced activation of the photoreceptor leads to a 
hyperpolarization of its membrane potential, rather than a depolarization, as it occurs in many 
other sensory neurons. All the biochemical events involved in the phototransduction have been 
deeply studied in the last four decades, and many of them are now well-characterized (for a 
complete review, see Kawamura and Tachibanaki, 2008). In the following sections, an overall 
picture of the most important steps in the phototransduction pathway will be given. 
 
1.6.1 The Dark Current 
In the dark-adapted state, the photoreceptors are maintained in a depolarized state by a flux of 
Na+ and Ca2+ ions that enter into the cells through specific ligand gated channels located in the OS 
membrane (Hagins et al., 1970). The open- or closed-states of these channels are regulated by the 
intracellular level of the nucleotide cyclic guanosine monophosphate (cGMP) (Fesenko et al., 1985; 
Yau and Nakatani, 1985b). In particular, in darkness, the high cytoplasmic concentration of cGMP 
keeps the channels open, and Na+ and Ca2+ ions are free to enter into the OS. This steady inward 
current is balanced by an outward K+ current that flows through non-gated K+-selective channels 
that are confined in the IS membrane (Bader et al., 1982; Barnes and Hille, 1989). Furthermore, in 
the IS membrane are confined several Na+/K+-ATPase pumps that are responsible for the 
maintenance of stable intracellular concentration of Na+ and K+ by pumping out Na+ ions and 
pumping in K+ ions (Zuckerman, 1973). The resulting circulating current stabilizes around -40 mV 
and is called “dark current” (Hagins et al., 1970). In the synaptic terminals, this relatively 
depolarized membrane potential generates the opening of voltage-sensitive Ca2+ channels, to 
which corresponds the release of glutamate (the photoreceptor neurotransmitter) toward the 
postsynaptic cell (Sarantis et al., 1988; Copenhagen and Jahr, 1989; Ayoub and Copenhagen, 
1991). Light activates an enzymatic cascade which ends with the hydrolysis of cGMP. This causes 
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the closure of the cGMP-gated channels, and in turn the reduction of the influx of Na+ and Ca2+ 
ions, the hyperpolarization of the cell, and finally the reduction of glutamate release at the 
synaptic terminal. 
 
1.6.2 Enzymatic Cascade Activation 
Since rod cells are easier to purify compared to cones, the best-characterized phototransduction 
pathway is so far the one occurring in rods (Figure 1.6), in which the visual pigment is the 
rhodopsin. Upon photon absorption, the 11-cis retinal, which is the light-sensitive moiety of 
inactivated rhodopsin (Rh), isomerizes to a more stable all-trans configuration in less than 20 ps, 
and triggers a conformational change of the entire molecule, that becomes enzymatically active 
(Rh*). In this state, Rh* catalyzes the activation of a G-protein, also known as transducing (G). 
Transducin is a heterotrimer whose α subunit bounds non-covalently to a molecule of GDP 
(guanosine diphosphate) when inactive. Upon interaction with Rh*, α subunit exchanges GDP with 
GTP, dissociates from transducin, and activates the cGMP phosphodiesterase (PDE). This enzyme 
causes the hydrolysis of cGMP into 5’-GMP: the fall of the cytoplasmic concentration of cGMP 
causes the closure of a number of cGMP-gated channels proportional to the amount of light 
initially absorbed. 
 
 
Figure 1.6 Phototransduction cascade activation by light. 
 
 
The dark current sustained in the OS by the entrance of Na+ and Ca2+ ions is therefore reduced, 
and the change in membrane potential can be detected by electrophysiological recordings 
performed on single isolated cells (Figure 1.7). This membrane hyperpolarization leads to the 
closure of the voltage-gated Ca2+ channels, and the intracellular Ca2+ concentration drops, due to 
continuous Ca2+ extrusion from the cell via the Ca2+ pumps (Yau and Nakatani, 1984, 1985a). The 
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decrease in Ca2+ concentration reduces or terminates the glutamate release at the synaptic 
terminal, which is detected by the postsynaptic neuron. The signal is further processed by other 
neurons present in the higher layers of the retina, and subsequently sent to the brain. 
This first step of the phototransduction cascade is characterized by an enormous level of 
amplification. A single rhodopsin molecule, when activated, can diffuse within the disc membrane 
and activate hundreds of transducin, each one of which stimulates one PDE enzyme. Each PDE in 
turn is able to hydrolyze over a thousand of cGMP molecules per second, leading to a final 
hydrolyzation of more than 105 cGMP molecules per second for a single Rh* (Leskov et al., 2000). 
 
 
 
 
 
 
 
 
 
 
 
1.6.3 Enzymatic Cascade Inactivation 
In order to maintain enough light sensitivity to respond to subsequent stimuli, it is essential for 
the photoreceptor to recover from its active state. This implies that all the molecules activated 
during the cascade need to be inactivated, and the cGMP concentration has to be restored. 
Transducin possess GTPase activity and is able to inactivate itself by hydrolyzing the bound GTP 
molecule into GDP, thus switching off also the PDE activity. At the same time Rh* becomes a target 
for phosphorylation by a rhodopsin kinase, which phosphorylates the C-terminus of Rh*. The 
phosphorylated Rh* then interacts with the protein arrestin, leading to its rapid inactivation and 
causing the dissociation of the all-trans retinal from the rhodopsin. In order to be restored into its 
11-cis active form, the all-trans retinal is reduced to all-trans retinol, transported out of the OS 
and converted in the RPE by appropriate enzymes (Lamb and Pugh, 2004). 
Figure 1.7 Electrical response of an 
isolated rod photoreceptor.  
Upper panel: The transient 
suppression of the current entering 
the outer segment in response to 20 
ms flashes of light of progressively 
increasing intensity, is recorded with a 
suction pipette;  
Lower panel: simultaneous voltage 
recording with an intracellular 
microelectrode impaling the inner 
segment. 
 
24 
 
Theoretically, once the PDE activity has been reduced, the restoration of the dark levels of cGMP 
would occur thanks to the basal activity of GC. In this case, however, the recovery rate would be 
too slow compare with the photoresponse kinetics: indeed, more mechanisms that regulate the 
transduction cascade must be involved. It is now well established that the responsible for the 
modulation of the photoresponse cascade is primarily, if not exclusively, the change of Ca2+ 
intracellular free concentration (Rispoli, 1998; Fain et al., 2001; Nakatani et al., 2002). 
 
1.6.4 Ca2+-Mediated Light Adaptation 
In order to adjust their sensitivity to different light intensities, photoreceptors are endowed with 
several mechanisms of light adaptation. In particular, these processes operate to increase the 
sensitivity of the transduction cascade in low-light conditions; whereas at higher levels of 
illumination the sensitivity decreases, preventing the receptors from saturating. The concentration 
of Ca2+ ions in the OS appears to play a key role in the light adaptation of photoreceptors, and it is 
also involved in the shut-off mechanisms described above (Fain et al., 2001; Nakatani et al., 2002). 
The most important Ca2+-sensor proteins involved in these mechanisms are recoverin (Rec), 
calmodulin, and guanylate cyclase-activating proteins (GCAPs). Recoverin plays a role in the 
inactivation of Rh*, since it activates the rhodopsin kinase when Ca2+ concentration decreases. 
Calmodulin, on the other hand, modulates the cGMP-gated channels. In darkness, when OS free-
Ca2+ is high, Ca2+-calmodulin is bound to the channels, and their affinity for cGMP is relatively low. 
As Ca2+ concentration decreases in light, calmodulin unbind Ca2+ and dissociates from the channels 
increasing their sensitivity to cGMP. Low Ca2+ concentration induces also the GCAPs to activate 
another enzyme, the guanylate cyclase (GC), thus promoting the cGMP recovery when the light 
stimulation is ceased. The regulation mediated by GCAP is the most powerful negative-feedback 
mechanisms triggered by Ca2+ in photoreceptors, since it has an effect on the photoresponse 
amplitude, on the recovery phase of the photoresponse, and also improve the signal-to-noise 
characteristics of the rod. 
Guanylate Cyclase-Activating Proteins (GCAPs) 
GCAPs are members of the neuronal calcium sensor protein family, a group of Ca2+-binding 
proteins that are mainly expressed in neurons, where they mediate a wide range of Ca2+-
dependent physiological responses (Burgoyne, 2007). The first observation that low Ca2+ 
concentrations in the OS stimulate the synthesis of cGMP was made in 1982 by Lolley and Racz, 
who conclude that Ca2+ has an inhibitory effect on GC (Lolley and Racz, 1982). Later, Koch and 
Stryer discovered that the activation of GC is not directly controlled by Ca2+ ions, rather is mediated 
by a specific Ca2+-sensitive protein (Koch and Stryer, 1988). This protein had been finally isolated 
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after several years of efforts by Gorczyca et al., and was called guanylate cyclase-activated protein, 
or GCAP (Gorczyca et al., 1994). 
From a structural point of view, GCAP are small proteins of approximately 200 amino acids, and 
contain four Ca2+-binding domains (of which the first is non-functional) which are termed EF-hand 
motifs (Figure 1.8) (Ermilov et al., 2001). GCAPs are expressed in photoreceptors of several 
vertebrates, and many isoforms have been specifically found in human, bovine, mice, chicken, fish, 
and amphibians (Palczewski et al., 1994; Subbaraya et al., 1994; Frins et al., 1996; Imanishi et al., 
2004). 
 
Figure 1.8 
Cartoon representation of GCAP1 with three Ca2+ bound. The N-terminal helix is red, N-terminal 
domain (EF-1 and EF-2) is orange, C-terminal domain (EF-3 and EF-4) is yellow, kinked C-
terminal helix is green, and the Ca2+ ions are shown as dark green space-filling spheres 
(modified from Stephen et al., 2007). 
The physiological role of GCAPs in the modulation of the photoresponse has been deeply studied 
during the last years. Mendez and Chen generated a transgenic mouse strain having the genes of 
the isoforms GCAP1 and GCAP2 knocked-out (GCAPs-/-) (Mendez and Chen, 2002). By comparing 
the flash responses recorded from rods of normal mice (GCAPs+/+) with the ones in GCAPs-/-, they 
discovered that responses triggered by flashes of same intensity were larger and slower in GCAPs-
/-. This indicates that the prevention of GCAP regulation in photoreceptors makes them more 
sensitive to light and unable to quickly recover their dark state following light stimuli, and adapt 
to background illumination. 
Zebrafish GCAP 
Within the last decade, the zebrafish (Danio rerio) has become a common and valuable vertebrate 
model in many branches of neuroscience, including embryology (Kimmel, 1993), developmental 
neuroscience (Barinaga, 1990), genetic analysis (Driever et al., 1994), and, of course, visual 
neuroscience (Bilotta and Saszik, 2001). The zebrafish retina is endowed with one type of rod cell 
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and four types of cone cells: short single cones (UV-sensitive), long single cones (blue-sensitive), 
and double cones (green- and red-sensitive). An interesting feature of zebrafish photoreceptors is 
the presence of six GCAPs isoforms, zGCAP1-6, which are expressed differently in rods and cones 
(Figure 1.9). Isoforms of zGCAP differ in their Ca2+ sensitivity and Ca2+-activating properties 
(Scholten and Koch, 2011). Compared with mammals, which express only two types of GCAP, the 
abundance of these proteins in zebrafish photoreceptors suggests a more intricate mechanism for 
the regulation of GC and for the photoresponse in general that  is not understood yet (Koch, 2013). 
 
 
  
Figure 1.9 Schematic summary of zGCAP expression in different type of cones.  
Upper table: comparison of the expression profiles of zGCAP isoforms among the different type of cones. 
Lower part: schematic design of double cones (LWS and MWS), long single cones (SWS) and short single 
cones (UV-sensitive).  
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1.7 Aim of This Work (pt. II):  
Role of zGCAP3 in Green-Sensitive Cones 
Among all the GCAP isoforms expressed in zebrafish cone cells, the zGCAP3 is a major regulator of 
GC activity (Rätscho et al., 2009). For this reason, its physiological function have been investigated 
in the last years, by using different approaches. Expression pattern and localization analysis 
revealed that zGCAP3 is expressed only in cone cells, and prominently expressed in the larval retina 
(Imanishi et al., 2004; Fries et al., 2013). Furthermore, phylogenetic analysis have shown that this 
isoform has a strong relationship with human GCAPs, while biochemical assays were carried out 
in order to study zGCAP3 affinity with GC (Imanishi et al., 2004; Fries et al., 2012). 
In the second part of this thesis work I investigated the role of zGCAP3 in the photoresponse 
cascade, employing a novel technique developed during my Ph.D. (Aquila et al., 2014). This 
technique allows the simulation of an over expression and a knock-down of this protein, by 
delivering it, or its monoclonal antibody, respectively, into an isolated zebrafish cone, while 
recording their photoresponses with the patch-clamp technique. The intracellular delivery of 
zGCAP3 and of its antibody was attained by ejecting them out of a tube inserted in the patch 
pipette lumen. A custom microperfusion system (see Materials and Methods) was employed to 
apply the exogenous molecules with a precise timing. However, the long tapered shape of the final 
part of the patch pipette, called shank, makes it very difficult to perfuse efficiently the cell with 
this strategy. For this reason, a pressure polishing setup has been assembled to enlarge the patch 
pipette shank, through the calibrated combination of heat and air pressure, that allowed to insert 
teflon tubes in the pipette lumen very close to its tip. 
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2. Materials and Methods 
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2.1 Peptides and Proteins 
2.1.1 AMPs and CPPs 
The primary structure of all peptides studied in this thesis is reported in Table 2.1. 
CM18-Tat11, CM18, and Tat11 peptides were synthesized and purified by the group of prof. Beltram 
of NEST laboratory (Scuola Normale Superiore and Istituto Nanoscienze-CNR, Pisa). CM12 was 
designed, synthesized and purified by Maccari et al. at NEST and IIT (Istituto Italiano di Tecnologia) 
laboratory in Pisa. These peptides were dissolved in bidistilled water to get a 500 μM stock solution 
and stored at −80 °C. Alm F50/5 and its analog [L-Glu(OMe)7,18,19] were dissolved in methanol to 
get different stock solutions and stored at −80 °C. For the experiments, an aliquot of the stock 
solution was dissolved in the perfusion solution to get a specific final concentration, and used 
within 30 minutes. Control experiments proved that the methanol contamination of the perfusion 
solution was no larger than 10 µl/ml and did not cause any non-specific membrane 
permeabilization (data not shown). 
Table 2.1  
 Primary sequence of the peptides studied. 
Peptide Sequence 
CM18-Tat11 Ac-KWKLFKKIGAVLKVLTTGYGRKKRRQRRRC-CONH2 
CM18 Ac-KWKLFKKIGAVLKVLTTG-CONH2 
CM12 Ac-WKLFLKAVKKLL-CONH2 
Tat11 Ac-YGRKKRRQRRR-CONH2 
Alm F50/5 Ac-UPUAUAQUVUGLUPVUUQQ-Phol 
[L-Glu(OMe)7,18,19] Ac-UPUAUAEUVUGLUPVUUEE-Phol 
 
2.1.2 zGCAP3 and IgG1 Monoclonal Antibodies 
Recombinant zGCAP3 (and its dansylated version) was purified from BL21 Escherichia coli cells 
overexpressing the protein, following known protocols (Behnen et al., 2009; Scholten and Koch, 
2011; Fries et al., 2012). IgG1 monoclonal antibodies (zG3 7E6-1-1; zG3 6G9-14; zG3 4C12-1-1; zG3 
6B9-11) directed against purified recombinant zGCAP3, were produced in the laboratory of Dr. 
Elisabeth Kremmer (Institute of Molecular Immunology, Helmholtz Zentrum München, 
Munich,Germany) using rabbits for immunization. IgG1 antibodies were raised against a synthetic 
peptide corresponding to the last 20 amino acids (168˗188) of the C-terminus of zGCAP3 (C-
KMMDLTHVLEIIVNGQKKKKE). 
31 
  
2.2 Solutions 
All chemicals, medium, and buffers were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Rod outer segments from Rana esculenta and cone cells from zebrafish were bathed in a Ringer’s 
solution having the following composition (in mM): 115 NaCl, 3 KCl, 10 HEPES (N-[2-
hydroxyethyl]piperazine-N’-[2ethasulfonic acid]), 0.6 MgCl2, 0.6 MgSO4, 1.5 CaCl2, and 10 glucose. 
Osmolality of all solutions was ≈ 265 mOsm/Kg and checked before experiment with an 
osmometer (Hermann Roebling, Messtechnik, Berlin, Germany). All solution were buffered to pH 
≈ 7.6 (for Rana esculenta) and to pH ≈ 7.4 (for zebrafish) with NaOH or KOH. 
In the experiments with AMPs and CPPs, the control solution, as well as the solution in which the 
peptides were dissolved, had the following composition (in mM): 130 KCl, 1 CaCl2, and 10 HEPES; 
buffered to pH ≈ 7.6 with KOH. The osmolality was corrected with sucrose to ≈ 260 mOsm/Kg in 
whole-cell recordings from OS, to ≈ 290 mOsm/Kg in whole-cell recordings from CHO-K1, and ≈ 
300 mOsm in excised-patch recordings from GUVs. 
For the whole-cell recordings from zebrafish cone cells, patch pipette were filled with an 
intracellular solution containing (in mM): 40 KCl, 70 K-Aspartate, 5 MgCl2, 1 GTP, 5 ATP, 5 HEPES; 
buffered to pH ≈ 7.4 with KOH. zGCAP3 and its specific antibodies were dissolved in the 
intracellular solution at a concentration of 40 µM and 6 µM, respectively. 
 
2.3 Cell Preparation  
2.3.1 CHO Culture 
Chinese Hamster Ovary (CHO-K1) cells were purchased from the American Type Culture Collection 
(CCL-61 ATCC). CHO-K1 were grown in 25 ml flask (Falcon, Becton Dickinson and Company; Franklin 
Lakes, NJ) in DMEM/F-12 medium (Dulbecco’s Modified Eagle’s Medium; Gibco® by Life 
Technologies) supplemented with 10% fetal bovine serum and 1% penicillin/streptomicin 
(PenStrep, Bio Whittaker Europe, Cambrex Company, Verviers Belgium). Cell cultures were stored 
in humidified environment at 37 °C and in 5% CO2, according to manufacturer’s instructions. For 
patch-clamp experiments, cells were washed three times in phosphate buffered saline buffer (PBS, 
Gibco® by Life Technologies) to remove medium residues and detached from plate by trypsination 
for 5 min in 0.25% trypsin-EDTA solution (Gibco® by Life Technologies). Subsequently, 1-2 ml of 
DMEM/F-12 were added in order to inactivate trypsin enzyme and the cell suspension obtained is 
transferred in a 15 ml tube with others 2-3 ml of medium. Approximately 1 ml of the suspension 
was then centrifuged at 6,000 rpm for 30-40 sec, and cell pellet dissolved in PBS for patch-clamp 
experiment. 
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2.3.2 Photoreceptor Isolation 
All experiments using animals were performed in accordance with the European Communities 
Council Directive for animal use in science (86/609/EEC) and approved by a local ethical 
committee. The experimental processes were designed to minimize animal number and suffering 
of the animals used. 
Rod outer segments used in the single channel studies with Alm and [L-Glu(OMe)7,18,19] were 
mechanically isolated from the retina of Rana esculenta. Animals were kept in filtered, running tap 
water in small tanks at room temperature (20-23 °C). 
Cone cells used in the study of zGCAP3 were mechanically isolated from the retina of Danio rerio 
(zebrafish). Adult zebrafish were kept in groups of 8-10 individuals in 50 liters aquaria with 
dechlorinated fresh water, continuously filtered and aerated, at constant temperature (28 °C) and 
maintained in a natural dark-light cycle. 
Before dissection, both frogs and zebrafish were dark adapted for ~2 hour at room temperature, 
deeply anaesthetized by immersion in tricaine methane sulphonate solution (1 g/l in water) and 
decapitated in dim red light generated by LEDs of wavelengths of 660 nm. The eyeballs of Rana 
esculenta were removed from the head and hemisected in a Petri dish containing Ringer solution 
(see Solutions). The back half of the eyeball was cut into four pieces that were stored in the same 
oxygenated Ringer solution. The retina was peeled from an eyecup piece and gently triturated in 
1-2 ml of Ringer solution, using a fire-polished Pasteur pipette to separate the rod outer segments. 
Since zebrafish eyes are smaller than the ones of Rana esculenta and in order to operate in 
completely dark conditions, cone cells of zebrafish were collected using a different method. After 
decapitation, the head was swiftly immersed in a Petri dish containing Ringer solution and 
transferred in a fully darkened box equipped with an infrared light (LEDs wavelength: 940 nm) and 
an HD webcam that had its infrared filter removed, connected to an external laptop. After inserting 
the hands through two light-tight holes of the box, the cornea of each eye was focused on the 
laptop computer screen and it was cut with small scissors. The retina was then gently sucked using 
a 200 µl precision pipette, by displacing the crystalline with the pipette tip. The two retinae were 
then ejected directly in the recording chamber and mechanically triturated with the same pipette. 
2.3.3 Cell Viewing 
An aliquot of ~2 ml of the appropriate solution containing the cells was transferred to the 
recording chamber placed on the microscope (TE 300, Nikon, Tokyo, Japan) stage. The preparation 
was illuminated with an ultra-bright infrared LED (900 nm) and focused on a fast digital camera 
(C6790-81, Hamamatsu Photonics, Tokyo, Japan) coupled to the microscope. The preparation was 
then viewed on a pc-monitor using the AquaCosmos software package (version 2.5.3.0, 
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Hamamatsu Photonics), which controls also all the camera parameters (like gain, exposition time, 
binning, etc.). 
 
2.4 GUVs Electroformation 
All phospholipids and cholesterol were purchased from Avanti Polar Lipids (Alabaster, AL, USA); 
chloroform and methanol were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Giant unilamellar vesicles (GUVs) were prepared using the electroformation method (Angelova 
and Dimitrov, 1986; Estes and Mayer, 2005).  
The composition of the lipid mix was: 60% egg-phosphatidylcholine, 10% egg-
phosphatidylglycerol, 30% cholesterol, and 0.2% NBD-labeled phosphatidylethanolamine. The 
lipids were dissolved in a chloroform/methanol (95:5) mixture to obtain a final lipid density of 1 
mg/ml. A 10 µl droplet of this lipid mix was spread on the charged side of an indium tin oxide (ITO) 
coated glass slide, using a Hamilton syringe and under a light stream of argon. The solvent was 
then completely evaporated under vacuum for at least 2 h. After this time, a thin lipid film was 
formed on the surface of the glass slide. A silicon spacer is then placed on the slide around the 
lipid film, and the electroformation chamber was closed using a second ITO-coated glass slide. The 
chamber was then closed with rubber bands or Parafilm and filled with a 300 mM sucrose solution. 
For the electroformation, a 1.5 V, 10 Hz potential was applied for 1 h, and then switched to 4 V, 4 
Hz for 15 min to promote detachment of GUVs from the glass surface. The solution containing 
GUVs (~500 µl) was gently removed with a syringe from the electroformation chamber, diluted in 
a solution containing 130 mM KCl and 1 mM CaCl2, and placed in the recording chamber under the 
microscope to check their formation and unilamellarity. 
2.5 The Patch-Clamp Technique 
The patch-clamp is a technique used for the first time by Neher and Sakmann (for which they 
received the Nobel Prize in 1991) that allows high-resolution recording of the ionic currents 
flowing through a cell membrane (Neher and Sakmann, 1976; Neher et al., 1978). The principle of 
this method, specifically of the voltage-clamp mode, is to electrically isolate a small part of the 
membrane (patch) and to measure the current necessary to maintain the membrane potential 
equal to that of the command circuit (Hamill et al., 1981). The membrane patch isolation is 
achieved by pressing the clean, smooth tip of a glass micropipette, which is filled with an isotonic 
saline solution, on the surface of the cell membrane and applying light suction (Figure 2.1). Under 
such conditions, the adhesion between the pipette and the membrane (called seal) is so tight that 
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the electrical resistance is greater than 1 GΩ. This high seal resistance reduces the current noise 
of the recording and allows a good resolution of single channel currents, whose amplitude is in the 
order of pA. 
 
Figure 2.1 
Schematic diagram of the patch-clamp technique. 
 
2.5.1 Patch-Clamp Configurations 
Depending on the type of experiment needed, different configurations of the patch-clamp 
technique can be used (Figure 2.2). The cell-attached configuration is simply achieved once the 
seal is formed, and allows recording of currents flowing through single ion channels enclosed by 
the pipette tip of the intact cell (Figure 2.2A). Once the cell-attached configuration is obtained, the 
micropipette can be quickly detached from the cell, thus breaking a patch of membrane that 
remains attached to the tip of the pipette. In this case, called inside-out configuration (Figure 
2.2B), the intracellular side of the membrane is exposed to the external solution, which can be 
manipulated by the experimenter. The whole-cell configuration (Figure 2.2C) is achieved from the 
cell-attached by perforating the membrane patch through the application of negative pressure. 
Under this condition, the solution of the pipette enters into the cytoplasm, and the current flowing 
through the entire cell surface can be recorded. The whole-cell configuration has been used in 
experiments with OS, CHO-K1, and cone cells, but could not be used for recordings from GUVs, 
too fragile, for which was used the inside-out excised-patch configuration.  
In the outside-out configuration (Figure 2.2D), once the whole-cell is obtained, the pipette is slowly 
withdrawn from the cell so that the patch of the membrane detaches from the cell and turns into 
a convex membrane, with the original outside of the membrane expose to the bath solution. 
Outside-out patch-clamp allows to examine the properties of an ion channel exposed to different 
analytes on the extracellular side. 
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Figure 2.2 Different patch-clamp configurations. A, cell-attached; B, inside-out; C, whole-cell; D, outside-out. 
 
2.5.2 Patch-Clamp Setup and Data Analysis 
The current was recorded employing a patch-clamp amplifier (Axopatch 200B; Molecular Devices, 
Sunnyvale, CA, USA). Recordings were usually filtered at 2 kHz via an eight-pole Butterworth filter 
(VBF/8 Kemo, Beckenham, UK), sampled on-line at 5 kHz by a Digidata 1322A (Molecular Devices) 
connected to the SCSI port of a Pentium computer running the pClamp 10.0 software package 
(Molecular Devices), and stored on disk. Data were further low-pass filtered off-line at 100, 200 or 
500 Hz using a Gaussian filter, or by using the running average routine of SigmaPlot (version 8.0; 
Jandel Scientific, San Rafael, CA, USA), and analyzed using Clampfit (version 10.0; Molecular 
Devices). Figures and statistics were performed using SigmaPlot; results are given as means ± SEM. 
 
A 
D 
C 
B 
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2.6 Pressure Polish Technique 
When performing whole-cell experiments, the patch pipette tapered shank (i.e. the final part of 
the pipette) and the small tip opening give high resistance to the passage of ions and molecules 
and preclude efficient exchange between pipette solution and cell cytosol. This resistance can be 
measured electrically, and it is called access resistance (Ra). Moreover, to faithfully record large 
currents (elicited by high concentrations of peptides and/or highly membrane permeabilizing 
ones), it is necessary to minimize Ra, in order to reduce errors in membrane potential control and 
time constant of charging the cell membrane capacitance. 
During my Ph.D. a new method to enlarge the pipette shank without affecting the tip-opening 
diameter has been improved, using the calibrated combination of heat and air pressure (Aquila et 
al., 2014). These pipettes, called “pressure-polished” pipettes, gave small access resistances, and 
allowed the accommodation of plastic perfusion tubes very close to the pipette tip (see 
Intracellular Perfusion section). 
 
2.6.1 Pressure Polish Setup 
Patch pipettes were pulled from 50 or 100 µl borosilicate glass capillary (Drummond, Broomall, 
PA, USA) using a vertical puller (Narishige PP-830, Tokyo, Japan). The pipettes obtained were 
tightened into a modified pipette holder connected to a pressurized air line (set to 4 atm and 
filtered with a 0.2 µm filter) through a three way valve (Figure 2.3). 
 
  
Figure 2.3 Setup to fabricate pressure-polished pipettes. Left, view of the microscope, the camera coupled 
to the objective nosepiece, the microscope stage, the ﬁlament holder, the LED illuminator, and the box; 
right, closer view of the microscope stage, the pressurized pipette holder, and the platinum ﬁlament. 
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The holder was clamped to a microscope stage and moved using the XY manipulator to center the 
pipette tip into the central bend of a platinum filament shaped in the form of an omega (Figure 
2.4) by using a needle of a 1 ml syringe and fine forceps. Thanks to this particular shape, the pipette 
shank was homogeneous softened when a constant current pass through the filament heating it. 
To avoid metal evaporation onto the pipette, the filament (50 µm of diameter) was previously 
uniformly glass-coated by dipping it in borosilicate glass powder while it was heated to red color. 
The filament was then tin soldered to two copper bars connected to form a holder (Figure 2.4), 
and mechanically coupled to a micromanipulator that allowed a precise positioning of the filament 
under the microscope. Finally, a variable high-current generator was remotely connected (or not) 
to the filament by a “push-to-make” switch.  
To follow the pressure polish 
process, it was necessary to view it 
on a LCD monitor: to this aim, the 
eyepiece of the microscope (YS2-
T, Nikon) was removed, and a 
contrast-intensified CCD camera 
(VX 44, Till Photonics, Gräfelfing, 
Germany) was coupled to the 
objective nosepiece through an 
ocular, a 0.6 neutral density filter 
and an infrared filter. The video 
signal could be recorded by 
digitizing it on-line (by Pinnacle 
Studio MovieBox DV, Avid, 
Burlington, MA, USA), stored on a 
computer, and further processed off-line. The pressure polish setup was enclosed in a box to avoid 
any changes in the filament temperature caused by air currents (which could strongly affect its 
temperature), and to protect the entire setup from dust. 
 
2.6.2 Pressure Polish Procedure 
Once the pipette is properly aligned with the filament, the three-way valve was set to connect the 
pipette lumen to the pressurized air line. The current generator was then turn on using the “push-
to-make” switch and keep it on, while following the shaping process of the pipette shank on the 
LCD monitor, until the desired shape is attain (Figure 2.5). 
 
Figure 2.4 Filament shape and pipette alignment. Top, Shape 
of the glass-coated platinum ﬁlament tin-soldered to the 
holder; scale bar 5 mm. The region within the white box is 
enlarged at bottom left. The omega-shaped region of the 
ﬁlament is enlarged at bottom right, pipette correctly aligned 
with the ﬁlament before pressure polishing; scale bar: 100 
µm. 
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The pressure procedure was controlled by five parameters listed below:  
a) the position of the pipette relatively to the omega-shaped, glass-coated platinum 
filament; 
b) the intensity of the current flowing in the filament (typically set to ~1.2 A); 
c) the duration of this current flow; 
d) the intensity of the pressure applied in the pipette lumen (~4 atm); 
e) the duration of this pressure application as the current is flowing in the filament. 
 
 
Figure 2.5 
Different pipette shanks obtained 
with the pressure ﬁre polishing. a, 
pulled pipette; b, the same pipette 
ﬁre polished without pressure 
(indistinguishable from the pulled 
one at this magniﬁcation); c–e, 
pulled pipettes similar to a, ﬁre 
polished with progressively longer 
pressure durations. Scale bar: 20 
µm. 
 
 
 
The most simple and efficient strategy to finely shape the shank profile and the tip opening section 
was to optimize and keep fixed the parameters a, b, and d while the c and e ones were adjusted 
each time in order to obtain the desired pipette geometry (Figure 2.5) and tip-opening diameter. 
Anyway, the fixed parameters had to be controlled every time the filament was changed (about 
every two/three months, or when the filament was compromised), because the correct 
positioning, as well as the intensity of current and air pressure could vary according to the length 
and shape of the filament. 
 
2.6.3 Intracellular Perfusion 
In respect to conventional pipettes, the pressure-polished ones provided a dramatic improvement 
of the electrical recordings, given by the huge access resistance decrease, and they doubled the 
rate of molecular diffusion between the pipette and the cell interior. This substantial improvement 
in cell dialysis allowed the perfusion of small molecules in the cytosol, permitting the modulation 
of a multitude of intracellular processes during the whole-cell recording. However, many 
substances that had to be delivered in the cell (especially proteogenic ones) cannot be added 
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directly into the pipette solution because they may stick to the glass tip and reduce the probability 
or even prevent the seal formation (Mathias et al., 1990). In these cases, it is required to add these 
molecules to the pipette solution at a desired time, at least any time after attaining the seal. It is 
anyway extremely important to control the intracellular delivery even of these molecules not 
affecting the seal formation, for instance when some control experiments need to be performed 
on the same cell before the delivery. This task can be accomplished by inserting a teflon tube inside 
the pipette lumen, filled with a solution containing the molecule under test that can thus be 
ejected into the pipette solution with a pulse of pressure applied to the tube lumen. Pressure-
polished pipette resulted to be very advantageous for this goal. The tubes could in fact be 
accommodated very close to the tip of these pipettes fabricated with a particularly enlarged shank: 
this would minimize the delay between the time when molecules were expelled out of the tube, 
and the time when they were in fact incorporated in the cell cytosol. Indeed, the enlarged pipette 
shank allowed the smallest teflon tubes to advance x ≈ 95 µm further than the conventional pulled 
pipette (Figure 2.6). 
 
 
Figure 2.6 A teflon tube positioned inside the lumen of a conventional pipette as close as possible to its tip 
(left); the same tube is inserted in a pressure polished pipette (right). Scale bar : 20 µm. 
 
In this way the perfusion delay (t) for a small protein (for instance with a diffusion coefficient D = 
10-6 cm2 s-1) is reduced by about 15 s, according to the three-dimensional diffusion equation in the 
absence of pressure: 
𝑡 =
𝑥2
6 ∙ 𝐷
 
 
The other end of the teflon tube comes out of the pipette, and then out of the holder through a 
side-port. The expulsion of the solution from the tube to the pipette, and subsequently to the cell, 
is performed by applying a positive pressure inside the teflon tube (previously filled with the 
solution under test) using a precision pressure generator connected with a “three-way” valve with 
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low dead volume. This valve is also connected to a syringe containing the test solution, in order to 
guarantee a constant supply of the solution (Figure 2.7C). 
To test the efficacy of the perfusion 
system, the kinetics of lucifer yellow 
(40 µM, dissolved in intracellular 
solution) loading into a cone cell was 
recorded in whole-cell configuration 
with the pressure-polished pipette 
sealed on the outer segment (Figure 
2.8A) or on the inner segment (Figure 
2.8C, upper panel). The fluorescence 
intensity was integrated in three 
different regions of the cone (upper 
extremity of the OS, at the pipette 
level, and in the IS; black, red, and green dots, respectively), plotted vs time and then normalized. 
The fluorescence rose in all three regions with roughly similar kinetics, regardless the pipette was 
sealed on the inner or on the outer segment of the cone. In Figure 2.8C, lower left panel, is shown 
a fluorescence image after 50 s of injection in the outer segment of dansylated zGCAP3; the same 
cell is shown in bright field in the right panel. 
 
Figure 2.7 Intracellular perfusion apparatus. A, Pressure 
generator; B, pipette holder; C,  precision syringe; D, 50 
ml syringe used to apply strong positive pressure to clean 
the pipette; E,  mouth piece used to gain the seal. 
 
Figure 2.8 Kinetics of lucifer yellow 40 µM loading into a whole-cell recorded cone with the pressure-
polished pipette. A, left panel, fluorescence image after 50 s of lucifer yellow perfusion of the cell 
shown in bright field on the right (seal on the OS). B, normalized fluorescence intensity integrated in 
the black, green, and red regions of A vs time; Lucifer yellow was injected at t = 0. C, lower left panel, 
fluorescence image after 50 s of injection in the OS of dansylated zGCAP3 of the cell shown in bright 
field in the right panel. Short white scale bars are 10 µm; long scale bars are 20 µm. 
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2.7 Fast Extracellular Perfusion 
In order to quickly apply the peptides on the cell or GUV membranes, a fast extracellular perfusion 
system is used (Vedovato and Rispoli, 2007). After the desired patch-clamp configuration is 
obtained (whole-cell for CHO-K1 and OS frog, excised-patch for GUVs), the patch pipette is aligned 
in front of a fast microperfusion system (Figure 2.9). The perfusion pipette was created by gluing 
together six-barrels made with precision, square glass capillaries of 500 µm of side. This pipette 
can be moved horizontally in front of the patch-pipette with a precision step motor, controlled by 
a user-friendly interface running in a computer connected to the microperfusion system via a serial 
port. Peptides are applied and removed in ~50 ms (see below) by moving the perfusion pipette in 
front of the patch pipette. This enables us to rapidly switch recorded cell, or GUV patch, back and 
forth from a stream of control perfusion solution to a stream of control perfusion solution to a 
stream containing the tested peptide dissolved in the same perfusion solution. Such an 
experimental strategy allows to quantitatively describe membrane activity by measuring the 
kinetics of current change following both peptide application and withdrawal. Patch pipette are 
filled with the perfusion solution to ensure that current is entirely driven by the holding potential 
(Vh). In the control solution, repetitive 10 mV pulses are routinely applied to check access 
resistance (Ra) and membrane resistance (Rm) stability. 
 
 
Figure 2.9 CHO-K1 cell recorded in whole-cell mode (shown enlarged in the inset) aligned in front of 
the multibarreled perfusion pipette (horizontal white arrows denote perfusion flows). 
 
The solutions flowing in the perfusion pipette are fed by means of 1 ml precision syringes 
(Hamilton, Reno, NV, USA), whose piston is moved by a DC motor controlled via the computer 
interface. The typical perfusion speed is 15 μl/min, therefore minimal amounts of peptide solution 
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(<500 μl) are required to perform peptide applications lasting more than half an hour. Once the 
syringes are emptied, an end-position switch stop the motor, and the syringes can be refilled by 
clicking on the Refill button. This command moves the six three-way valves in the cylinder position 
and backs up the DC motor at full speed until the syringes are filled: the motor is then stopped by 
a second end-position switch. 
When using particularly precious solutions (such as AMPs and CPPs), all the perfusion lines are 
filled with control solution and the connectors to the perfusion pipette were detached, connected 
to a needle and immersed in the vials containing the peptide solutions. The syringe motor is then 
set to Reverse Mode and the solutions fill just the terminal portion of the tube between the valve 
and the perfusion pipette. The connectors are then replaced and the motor is set to Forward Mode 
to apply the solution to the cell. At the end of the experiment, all the perfusion lines can be washed 
by dipping all the tubes previously dipped in the cylinders, into a container filled with distilled 
water (or other washing solution, such as ethanol, DMSO, sodium hypochlorite), and clicking the 
Wash button. This command activated the valves and moved the motor back and forth at full 
speed, so that the syringes are firstly emptied through the perfusion pipette and refilled with the 
wash solution, a number of times set by the user in a sub-window opened by the Wash button. 
2.8 Light Stimulation and Calibration 
Light stimuli (flashes in the dark and flashes on a background of light) were delivered on zebrafish 
cones using voltage protocols loaded on pClamp software (Molecular Devices, Sunnyvale, CA, 
USA). One of the two analogical outputs of the Digidata 1322A (Molecular Devices) was connected 
to a calibrated voltage-to-current converter driving an ultra-bright LED of a wavelength of 550 nm. 
The LED was mounted on a miniaturized xyz micromanipulator, coupled to the binocular port of 
the inverted microscope and aligned so to have its light spot automatically centred and in focus 
on the zebrafish cone. Contemporarily the cone was viewed in sharp focus through a 60x objective 
on the microscope camera using an ultra-bright infrared LED replacing the microscope illuminator. 
Enough space was left between the LED and the binocular port to host neutral density filters, when 
required; the LED positioning and the measure of its spot size, were performed with the following 
procedure. First, a particular subdivision of the grid of a calibrated microscope slide was focused 
and centered on the inverted microscope 60x objective, by using the microscope infrared LED. 
Then a straight microscope, mounted on a second xyz micromanipulator, was aligned to the 
inverted one, and it was moved so to have its 60x objective focused and centered on the same 
grid subdivision, by using the LED as a light source. The LED spot, observed with the straight 
microscope, was finally focused and centered with its xyz manipulator on the grid subdivision, and 
its geometry measured (it resulted a uniform disk of 300 µm of diameter). The microscope slide 
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was then replaced by the sensor (OP-2/LM-2 VIS, Coherent, Santa Clara, CA, USA) of a 
power/energy meter (Fieldmaster, Coherent), and the light power produced by the LED at all the 
voltages used in the experiments was measured. Voltages, neutral density filters and light stimulus 
duration were matched so to have a wide range of light intensities spanning more than 5 order of 
magnitude, with currents always falling in the LED linear range (1-10 mA). 
To estimate the physical collecting area of the zebrafish cone outer segment (the functional 
collecting area cannot be estimated since cones do not detect single photons) it is necessary to 
know the quantum efficiency of photoisomerization and the specific axial rhodopsin density 
(Baylor et al., 1979). Moreover, it is difficult to have a reasonable estimate of the cone rod outer 
segment volume, since it is strongly invaginated, its geometry cannot be simply assimilated to a 
truncated cone, and its small dimension make it difficult to precisely measure the diameter of its 
base and of its tip. The geometrical area of the cone OS was measured on digital micrograph 
obtained with the camera (494x674 pixels, 0.2 µm per pixel), by using a freeware image analysis 
software (ImageJ, http://imagej.nih.gov/ij/) and it resulted 15.3 ± 3.9 µm2 (n = 20). Using the ratio 
between the geometrical rod outer segment area and the collecting area of ~0.062 calculated by 
Baylor et al. in 1979, it can be roughly estimated that the zebrafish cone collecting area is ~1 µm2 
(Baylor et al., 1979). If this line of reasoning proves to be correct, then the numerical values of the 
flash intensities reported throughout the paper (in photons/µm2) are also the number of photons 
absorbed by the cone. 
2.9 Fluorescence Imaging 
Besides bright field viewing of the cells, the camera and the AquaCosmos software were employed 
for fluorescence imaging experiments as well. The excitation light was generated by a 
monochromator (Polychrome II, Till Photonics) coupled to the epifluorescence port of the 
microscope via an optical fiber. Solution and protein loading in the cell was checked by using 
zGCAP3 labeled with dansyl chloride (concentration: ~20 µM; excitation: 280 nm, emission: 400 to 
600 nm) and with lucifer yellow (CH, dilithium salt; concentration 40 µM; excitation: 425 nm, 
emission: 528 nm), once the whole-cell configuration was gained. Dansylation of zGCAP3 (degree 
of dansylation: 16-22%) was performed as described in Fries et al., 2012. Incorporation of 
fluorescent zGCAP3 into the zebrafish cone cytosol (Figure 2.7) was rapid and sufficient to measure 
possible modifications of the photoresponse waveform induced by application of either purified 
zGCAP3 or an anti-zGCAP3 antibody. 
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3. Results and Discussions 
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Part I 
Membrane Active Peptides:  
Biophysical Characterization in Natural and Model 
Membranes 
 
 
 
3.1 Electrical Properties of CHO-K1 Membrane 
The mechanism of membrane permeabilization induced by the chimeric peptide CM18-Tat11 are 
studied by perfusing this peptide (and its isolated moieties) on the membrane of the CHO-K1 cells 
(see Materials and Methods). This goal is achieved by recording the ion current through the 
channels formed by these peptides, once inserted in a cell plasma membrane. To avoid 
contamination by the cell membrane currents, all the endogenous current sources must be 
blocked, possibly without using any drug (such as tetrodotoxin, tetraethlylammonium, 
dihydropyridines, etc.) that could obstruct the peptide pores or interfere with the pore formation. 
In line with previous reports on CM18-Tat11 (Salomone et al., 2012, 2013), we choose the CHO-K1 
cell line as case study. Nicely, we find that, in symmetric ionic conditions, CHO-K1 cells have no 
voltage- and/or calcium- and/or time-dependent conductances, but only a very small background 
one. 
Indeed, the current amplitude is time-independent and very small for any physiological voltage 
value (Figure 3.1A). We observed a linear (ohmic) current-to-voltage behavior (Figure 3.1B) and a 
membrane resistance (Rm) > 5 GΩ. Such high Rm values make it possible to measure current 
amplitudes as small as 1 pA in a bandwidth of at least 1 kHz (i.e., any exogenous peptide-induced 
current can be detected down to the single-channel level). Thanks to this high recording 
resolution, we set the holding potential (Vh) = −20 mV in order to limit the current amplitude 
induced by the strongly permeabilizing peptides while ensuring a detectable current through the 
weaker ones. 
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3.2 Peptide Activity Properties 
My goal here is to employ the patch-clamp technique to study the mechanism of membrane 
permeabilization induced by the chimeric peptide CM18-Tat11, under strict physiological conditions. 
The patch-clamp technique allows to record the currents flowing through the pores formed by 
these peptides once they are inserted in a plasma membrane. With an appropriate analysis of 
these currents, it is possible to distinguish the mechanism of action used by the peptide under 
study. 
In general, the waveform of the current induced by peptide application and removal can be 
described quantitatively using the following kinetics parameters: 
a) the delay of the activation, which represent the time lag between peptide application and 
the time in which the current deviates from its baseline more than three times the noise 
average fluctuation; 
b) the activation time constant (τa), defined as the time constant of the single exponential fit 
to current activation; 
c) the current amplitude at steady-state (Imax); 
d) the deactivation time constant (τd), defined as the time constant of the single exponential 
fit to current deactivation (upon peptide removal). 
Figure 3.1 Biophysical characteristics of CHO.K1 membrane. 
(A) Average whole-cell current recorded from representative cells (lower panel; pipette and external 
solution: 130 mM K+ + 1 mM Ca2+), subjected to 125 ms voltage steps from -80 mV to +80 mV in 20 mV 
increments (top panel) starting from Vh = 0 mV (traces are the average of n = 6 cells); (B) the average 
current evoked by each voltage step of A is plotted against the voltage step amplitude; the points are 
well fitted by a straight line (correlation coefficient ~0.99), whose angular coefficient gave Rm ~6.1 GΩ. 
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To avoid any error produced by the noise, the above parameters were measured on low-pass 
filtered traces. 
Since CM18-Tat11 does contain a functional antimicrobial peptide (CM18), it is conceivable that it 
may act by one of the three recognized mechanisms of membrane permeabilization proposed for 
this class of peptides, which are the “barrel-stave”, the “toroidal”, and the “carpet” model (see 
Introduction, part I). 
The barrel-stave model requires that a certain number of monomers bind together once they get 
in contact with the plasma membrane and assemble to form an ion conductive pore. If the number 
of monomers inserted in the membrane is small, as it occurs at low concentrations of a peptide 
like gramicidin (Killian, 1992), it is expected that the pores form and disaggregate frequently, 
producing sustained single channel events. The application of larger peptide concentrations is 
likely to produce macroscopic currents that recover to zero after extracellular peptide removal, 
because the interaction between the membrane and the peptide monomers is not strong enough 
to keep the peptides stably inserted once the extracellular supply is ceased. Consequently, the 
kinetics of current activation and deactivation and its amplitude are expected to be constant at 
each peptide application. 
In the case of the toroidal model, the molecular attractive forces between the polar head groups 
of the lipids and the peptides are so strong that the lipids are forced to tilt up and form pores 
whose walls are constituted by both lipids and peptide monomers. Such a strong interaction, 
however, is not expected to produce rapid pore formation and disaggregation at low peptide 
concentrations (i.e. sustained single-channels events), while larger peptide concentrations are 
expected to produce macroscopic currents with a delay, τa, and τd larger than in the case of the 
barrel-stave process. This is because of the longer time needed to form pores whose walls are not 
composed just by peptide monomers but by tilted lipids and peptides, and because of the longer 
time to disassemble this stable structure when extracellular peptide supply is ceased. If the 
peptide application is short and at low concentration, the monomers left on the membrane after 
peptide removal do not have a concentration large enough to give rise to conductive pores: these 
peptides may yet contribute to form additional pores once the peptide is applied again to the 
extracellular side. Therefore, repeated peptide applications are expected to elicit currents that 
only initially recover to the zero level upon peptide removal, and then produce a progressive 
acceleration of the current-activation kinetics (i.e., decrease of delay and τa), and a progressive 
increase of the steady-state current amplitude. This would eventually lead to the formation of 
stable conductive channels, which would produce progressively larger background currents upon 
peptide removal. All these features were previously observed with CM15, a peptide well-known to 
form pores according to the toroidal model (Milani et al., 2009), and are therefore considered in 
the following as a “signature” of this particular permeabilization process. 
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Finally, the “signature” of the carpet mechanism is given by two main observables. The first one is 
a larger delay with respect to the one characterizing current activation in the toroidal and barrel-
stave mechanisms, due to the expected slow process of micelle formation. The second one is the 
substantial irreversibility of the permeabilization process, caused by the membrane disruption in 
a detergent-like fashion, as observed in the case of viroporins (Madan et al., 2007). 
In a characteristics measurement, isolated CHO-K1 were held at Vh, and Rm was checked before 
peptide delivery by means of a brief −10 mV step (Figures 3.2, 3.3, 3.5, asterisks). Furthermore, to 
simplify the interpretation of the experiments, patch pipettes were filled with the same perfusion 
solution (that typically contained 130 mM of KCl and 1 mM of CaCl2) to ensure that the current 
was only driven by the holding potential (usually set to -20 mV). Various concentrations of CM18-
Tat11 (or CM18, or Tat11) were then delivered in ~50 ms using the fast-perfusion system. Once the 
peptide current was stable, the cell was quickly returned to the control solution (without peptide) 
to assess the possible current level recovery, and Rm was again measured. In the control solution, 
repetitive 10 mV pulses were routinely applied to check access resistance (Ra) stability (Figure 3.3, 
triangles), otherwise the recording was terminated. 
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3.3 Membrane-Disruptive Properties of CM18-Tat11 
CM18-Tat11 continuously applied for more than 1 min at various concentrations (0.5 µM, n = 2; 1.0 
µM, n = 3; 2.0 µM, n = 4; 3.0 µM, n = 5) on the CHO-K1 membrane failed to elicit detectable currents 
down to single-channel events. A typical example is shown in Figure 3.2, inset, in which the current 
did not significantly deviate from the zero level following a ~100 s application of 3 µM CM18-Tat11. 
On the contrary, application of 4 µM CM18-Tat11 elicited a current that developed in a roughly 
exponential trend (τa = 1.5 ± 0.4 s) up to a steady-state amplitude of 1.0 ± 0.2 nA (n = 15 cells) with 
a delay of 2.6 ± 0.5 s. As shown by the representative curve in Figure 3.2, the induced membrane 
permeabilization was extensive, as the evoked current did not fully recover to the baseline even 
after several seconds from peptide removal (see Figure 3.5 for more details). These recordings 
were very similar to the ones obtained with a viroporin-derived peptide (Madan et al., 2007), 
acting in a carpet-like fashion. 
 
 
 
Figure 3.2 Whole-cell current recording elicited by the application of 4 µM CM18-Tat11. 
Black bar: duration of peptide delivery (6.7 s).  
Inset: 113 s (grey bar) application of 3 µM of CM18-Tat11; Rm was 1.3 GΩ before and 1.0 GΩ after 
CM18-Tat11 application. 
Asterisks: -10 mV pulse delivery to measure Rm. 
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3.3.1 Isolated CM18 and Tat11 Peptides 
Given the structural/functional modularity of CM18-Tat11, we used the two isolated CM18 and Tat11 
peptides as controls for the observed behavior. CHO-K1 cells exposed to CM18 concentrations from 
0.5 to 4 µM always showed detectable membrane currents, i.e. membrane destabilization. In 
particular, the application of 4 µM CM18 elicited a current with a delay = 0.9 ± 0.2 s up to an Imax = 
1.0 ± 0.1 nA; with a τa, and τd equal to 2.1 ± 0.7 s and 3.7 ± 1.0 s, respectively (n = 7 cells). 
Application of 2 µM CM18 elicited a smaller current (Imax = 0.36 ± 0.07 nA) with a delay = 3.6 ± 1.1 
s, τa = 4.0 ± 1.1 s, and τd = 3.2 ± 1.0 s (n = 6 cells). However, concentrations < 2 µM yielded activation 
and deactivation currents that could not be simply fitted with a single exponential and statistics 
are therefore not reported. 
Contrary to what was found for CM18-Tat11, when the isolated CM18 was applied on CHO-K1 
membrane, the permeabilization was fully reversible, upon peptide removal, for all tested 
concentration. This means that the current returned roughly exponentially to zero, and Rm fully 
recovered to its initial level (representative curve in Figure 3.6, dark grey trace). However, as 
shown in a typical recording in Figure 3.3, for repetitive CM18 applications at 4 µM, the recovery of 
current and of Rm was progressively more incomplete. 
 
Moreover, the current-to-voltage relationship was found to be linear (Figure 3.4), meaning that 
the peptide insertion in the membrane and the pore formation were not facilitated or hindered 
by the membrane voltages (unlike other pore-forming peptides, as alamethicin). This relationship 
Figure 3.3 Whole-cell current recording elicited by five consecutive applications and withdrawals of 4 
µM CM18 on CHO-K1 cells lasting, in sequence, 6.1, 5.2, 4.7, 6.2, and 4.1 s (black bars). The parameters 
characterizing each current were respectively: delay: 1.7, 1.0, 0.9, 0.9, 0.9 s; τa: 1.5, 1.2, 0.8, 0.7, 0.7 s; 
Imax: 1.8, 1.9, 2.0, 2.1, 2.0 nA; τd: 4.3, 4.4, 4.3, 6.0, 5.2 s. Rm and Ra were checked before and after each 
peptide application by means of a single −10 mV pulse (asterisks), and sometimes by repeated 10 mV 
pulses (triangles); grey dotted line: zero current; Vh = −20 mV. 
 
52 
 
was obtained by applying voltage ramps (from -50 mV to +50 mV, slope = 0.25 mV/ms) during 
constant CM18 perfusion. To avoid the loss of voltage control due to Ra at extreme voltages (-50 
mV and +50 mV, were the currents may become very large), CM18 was applied at 2 µM 
concentration, corresponding to a current not exceeding 2 nA at extreme voltages. The responses 
to three consecutive voltage ramps during CM18 perfusion were averaged and corrected by 
subtracting the average of the responses obtained from three voltage ramps recorded in control 
conditions. 
The resulting current-to-voltage 
relationship was almost perfectly 
ohmic at physiological voltages (Figure 
3.4), and in all the cells examined (n = 
4). Notably, all the recordings 
obtained with CM18 were very similar 
to the ones obtained with the 
analogous CM15 hybrid peptide (Milani 
et al., 2009). Previous investigation on 
CM15 activity performed by patch-
clamp analysis and site-directed spin-
labeling electron-paramagnetic-
resonance studies (Pistolesi et al., 2007) indicated that it forms transient toroidal pores in the 
membrane. This suggests that CM15 and CM18 share the same membrane-destabilization 
mechanism. 
Finally, continuous application of Tat11 (up to 5 min) at concentrations from 0.5 to 8 µM failed to 
elicit any current for all voltage values tested (from -80 mV to +80 mV), thus demonstrating that 
this module alone is not able to significantly permeabilize the membrane (Figure 3.6, light grey 
trace). 
 
3.3.2 Comparison between CM18-Tat11, CM18, and Tat11 
In order to provide a direct comparison between membrane-destabilization properties of CM18-
Tat11 and CM18, we recorded data during sequential administration of these peptides to the same 
cell at 4 µM (Figure 3.5A). As expected, CM18 produced a reversible current, while CM18-Tat11 
leaded to irreversible membrane destabilization of the same cell. Increasing the peptide 
concentration to 8 µM still produced a reversible effect in the case of CM18 (although with an 
incomplete recovery, Figure 3.5B) while cell lysis and death were observed in the case of CM18-
Tat11 (Figure 3.5B, and 3.5B inset, experiment performed on the same cell). 
Figure 3.4 Voltage dependence of the current elicited 
by 2 µM CM18 applied on CHO-K1 cell, corrected for the 
leakage. 
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In order to give an overall comparison of the three peptides, in Figure 3.6 are gathered whole-cell 
currents recording elicited by the application (in three different cells), of CM18-Tat11 (6.7 s, 4 µM; 
black bar and black trace), CM18 (7.0 s, grey bar and grey trace), and Tat11 (71 s, 8 µM; white bar 
and light grey trace). 
 
 
 
Figure 3.5 (A) Current elicited by application (7 s) and withdrawal of 4 µM CM18 (grey bar) and of 4 µM CM18-
Tat11 (3 s, black bar) on the same cell. (B) Current elicited by application and withdrawal of CM18 (9 s, 8 µM; 
grey bar) and of CM18-Tat11 (7 s, 8 µM, black bar) on the same cell; inset, lysis and death of cell following >10 
min application of CM18-Tat11. Rm was checked using -10 mV pulses (asterisks); Vh = -20 mV. 
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Figure 3.6 Kinetics of peptide-induced membrane permeabilization of CHO-K1 cells. Currents elicited by 
application (on 3 different cells), of CM18-Tat11 (6.7 s, 4 µM; black bar and trace), CM18 (7.0 s, grey bar and 
trace), and Tat11 (71 s, 8 µM; white bar and light grey trace; trace break: 33 s of uninterrupted Tat11 
perfusion); Vh = −20 mV. Asterisks: -10 mV pulse. 
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3.4 Membrane-Disruptive Properties of CM12 
CM12 sequence was selected by Maccari after optimization and reduction of CM18 sequence, 
performed using a new introduced algorithm: the Minimum and Maximum of auto- and cross-
covariances descriptor (for more information, see Maccari et al., 2013).  
In order to study the mechanism of membrane permeabilization induced by the rational designed 
peptide CM12, the same experimental conditions used for CM18-Tat11 were maintained. 
Concentrations of CM12 < 1 µM gave no detectable macroscopic currents nor single channel 
events, while applications of CM12 ranging from 1 to 3 µM elicited currents with a delay = 9.1 ± 1.7 
s up to an Imax = 0.6 ± 0.2 nA (n = 5; Figure 3.7A). Similarly to CM18, the current did not return to 
the zero level following peptide removal; rather, the current recovered to a plateau level and the 
Rm measured on this plateau was consequently smaller in respect to the one measured before the 
CM12 application. When peptide concentration was raised up to 4 µM, CM12 elicited larger currents 
(Imax = 1.9 ± 0.6 nA) with a shorter delay (1.1 ± 0.2 s, n = 7). Moreover, after peptide removal in this 
case we did not see any recover of the current, suggesting an extensive membrane 
permeabilization as the one observed with CM18-Tat11 (Figure 3.7B). To assess the potential voltage 
dependency of the current elicits by CM12, we applied the same rapid voltage ramps used with 
CM18 (from -50 mV to +50 mV, slope: 0.25 mV/ms) during continuous peptide perfusion and in 
control conditions. As in the case of CM18 peptide, the resulting current-to-voltage relationship 
(after averaging and control subtraction) was almost perfectly ohmic for physiological voltages 
(Figure 3.8) in all cells examined (n = 4). 
 
 
 
Figure 3.7 Currents elicited by application (on 2 different cells) of CM12 with a concentration of (A) 1 µM (6.7 
s), and (B) 4 µM (7.0 s). Red bars indicate peptide application. 
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Figure 3.8 
Voltage dependence of the 
current elicited by 1 µM CM12 
applied on CHO-K1 cell, corrected 
for the leakage. 
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3.5 Single-Channel Properties of F50/5 and [L- Glu(OMe)7,18,19] 
In order to study the single channel properties of F50/5 Alm and [L-Glu(OMe)7,18,19] Alm, and to 
assess their possible dependence on membrane composition, the peptides were inserted in the 
plasma membrane of an isolated frog rod outer segment (OS; recorded in whole-cell 
configuration), and in patches excised from GUVs. The peptides were applied to the membrane at 
concentrations low enough to give single-channels events, avoiding the development of 
macroscopic currents. Isolated OS was previously been proven to be an ideal preparation to study 
pore-forming peptides under strict physiological conditions (Vedovato and Rispoli, 2007). GUVs 
had a diameter > 10 µm, and were prepared by using the electroformation method (see Materials 
and Methods). 
F50/5 Alm produced single-channel events of repetitive amplitude both in OS (Figure 3.9) and in 
GUVs (Figure 3.10). The larger events were usually an integer multiple of a fixed size. Since the 
events recorded in the OS were smaller than in GUVs, in the former case the traces were low-pass 
filtered at 100 Hz (Figure 3.9) which would otherwise cover most of these events. In the OS, single-
channel events produced by F50/5 Alm at concentrations ranging between 0.25 and 0.5 µM 
manifested within 5 s from peptide application. The current amplitude of single-channels resulted 
of ~50 ± 8 pS at -20 mV (3500 events; n = 3 cells). In GUVs, under the same ionic and voltage 
conditions, it was necessary to raise the peptide concentration to 1-2.5 μM to obtain single-
channel events, which again manifested within 5 s from peptide application. Since the single-
channel events were about 5-fold larger than the OS, the recordings were filtered at 2 KHz, instead 
of 100 Hz.  
 
 
Figure 3.9 Single-channel properties of Alm inserted in an OS.  
A: single-channels recorded during application of F50/5 Alm  
B, left: channel activity produced by [L-Glu(OMe)7,18,19] Alm, low-pass filtered at 2 KHz (grey trace) and 
at 100 Hz (superimposed black trace). Right: cumulative current amplitude distribution. Vh=-20 mV, same 
scales; continuous and dotted lines indicate the most probable single-channel amplitudes and 0 pA, 
respectively. 
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Although larger events were occasionally recorded not being an integer multiple of a fixed size, 
the cumulative distribution of current amplitudes in 3 GUVs (6500 events) gave at least 5 peaks 
equally separated by about 5 pA, corresponding to a single-channel amplitude of 250 ± 20 pS. 
 [L-Glu(OMe)7,18,19] Alm produced larger events than F50/5 Alm in both OS and GUVs. Many 
different amplitudes were observed, but some were so fast that they were cut by the patch-clamp 
amplifier, even when filtering as high as 2 KHz (Figure 3.9B, left, grey trace). Since the majority of 
the events were anyway much slower, in order to compare the single-channel amplitude for [L- 
Glu(OMe)7,18,19] Alm in the two lipid environments, these very fast events were usually cancelled 
out upon low-pass filtering the traces at 100 Hz (Figure 3.9B, left, black trace; Figure 3.10B, left). 
 
 
Figure 3.10 Single-channel properties of Alm inserted in GUVs.  
A, left: single-channels recorded during application of F50/5 Alm (Vh = -20 mV). Right: cumulative 
distribution of the current amplitudes. 
B, left: single-channels recorded during application of [L-Glu(OMe)7,18,19] Alm (Vh = -56 mV). Right: 
cumulative distribution of the current amplitudes. Arrows indicates the most frequent 
conductances, of ~250 and ~470 pS. 
 
In the OS, current activated ~20 s after peptide application at Vh = -20 mV, due to the very low 
probability of pore formation by this peptide (Vedovato et al., 2007). The distribution of current 
amplitudes showed that the most probable amplitude was 310 ± 30 pS (820 events, n = 3; Figure 
1B, right), but events of smaller sizes (as 260 pS) were recorded as well. In GUVs, the events at Vh 
= -20 mV were very scarce; therefore, Vh was raised to more negative voltages to obtain a sustained 
channel activity. Many different channel amplitudes were recorded: the two major peaks of their 
cumulative distribution gave the most frequent conductances of ~250 and ~470 pS (Figure 3.10B, 
arrows; 1400 events, n = 3). 
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3.6 Discussion 
The data collected from the study of CM18-Tat11 indicated that this peptide possess a stronger 
membrane activity compare with the single CM18 peptide. Indeed, an irreversible membrane 
destabilization is observed when concentrations ≥ 4 µM of CM18-Tat11 are delivered on the CHO-
K1 membrane, while same concentrations of CM18 gave reversible permeabilization. This could 
originates from the high positive charge density of Tat11 (rich in arginine residues), which leads to 
a stronger interaction of the peptide with the phospholipid head groups and to consequent 
membrane carpeting effect (Figure 3.11). However, it cannot be excluded that Tat11 may strongly 
promote membrane partitioning of CM18 up to a point that some of the resulting toroidal pores 
(characteristic of CM18 action) group together to delimit the contour of a micelle, that may 
eventually separate from the membrane and pass in solution. 
 
 
Figure 3.11 Schematic representation of the membrane destabilization mechanism proposed for CM18-Tat11 
(left) and CM18 (right) peptides. CM18 moiety is pictured as a red helix, while Tat11 moiety is represented as 
an unstructured blue segment. The upper part describes for each peptide its hypothetical membrane 
distribution when it is administered in the range between 0.5–3 µM. Instead the lower section represents 
the membrane distribution at concentrations higher than 4 µM. 
 
This observations allow us to readily explain the reported results on this peptide as a delivery 
vector (Salomone et al., 2012, 2013). It can be argued that CM18-Tat11 enters the cell with no 
membrane perturbing effects at low (i.e., nanomolar) concentrations by means of the endocytic 
pathway, as already demonstrated (Salomone et al., 2012). Then, during the physiological 
vesicular trafficking, the peptide eventually reaches its critical membrane-perturbing 
concentration (≥4 µM), dissolves the bilayer integrity by a carpet mechanism, and promotes the 
release of the co-administered macromolecules that specifically target the same route. 
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The strong effect observed with the rational designed peptide CM12 demonstrates that natural-
derived peptides, as CM18, can be optimized in order to maintain, or even improve, their 
antimicrobial activity, while at the same time reducing their length and thus lowering synthesis 
requirements. Despite a nearly 30% decrease in the chain length, application of CM12 on CHO-K1 
membrane elicited reversible macroscopic currents that were comparable with the one observed 
with CM18. This data confirmed previously studied where the peptides activity has been validated 
in vitro by testing the minimum bactericidal concentration against S. aureus and P. aeruginosa 
strains, representative of Gram-positive and Gram-negative bacteria, respectively (Maccari et al., 
2013). Moreover, similarly with CM18, the insertion of CM12 into the cellular membrane was found 
to be voltage-independent, suggesting that they act with the same mechanism of 
permeabilization, i.e. toroidal mode. However, for concentration of CM12 ≥ 4, it was observed an 
irreversible destabilization of the membrane that could be due to a stronger activity of this 
peptide, which forms larger toroidal pores that at some point can fuse together and promote the 
detachment of membrane fragments. 
Finally, the comparison between F50/5 Alm and [L- Glu(OMe)7,18,19] Alm inserted in both OS and 
GUVs, demonstrated that the latter peptide has a lower probability to form channels, but produces 
larger events than F50/5. These results are in line with the studies of the macroscopic currents 
elicited in frog OS and recorded using the whole-cell configuration (Vedovato et al., 2007). Despite 
both peptides generated larger events in GUVs than in OS, the overall similarity of the results 
obtained with these peptides in both lipid environments confirm that unilamellar vesicles 
represent a reliable model for preliminary studies of AMPs. However, the cellular model is still the 
best choice to precisely assess their in-situ properties. 
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Part II 
Real-Time Modulation of zGCAP in Zebrafish Green Cones 
 
 
 
3.7 Recording Stability and Response Waveform 
The final objective of this section is to record with the patch-clamp technique the response 
waveform of an isolated zebrafish cone to controlled light stimuli, and provide new data to better 
understand the strong Ca2+ regulation on excitation and adaptation mediated by the Ca2+ sensor 
and GC activator zGCAP3. To this aim, experiments were performed to simulate the over-
expression and down-regulation of this protein, by delivering it or its monoclonal antibody in a 
whole-cell recorded cone cell. Light responses of zebrafish cones were recorded using the whole-
cell configuration of the patch-clamp technique under dark-adapted condition at room 
temperature (20-22°C); the holding potential was always -40 mV. Light stimuli were delivered 
using an ultra-bright LED (see Materials and Methods). 
Before delivering the proteins in the zebrafish cone cytosol, it was essential to assess first that the 
photoresponse waveform remains stable for several minutes, at least for the time required to 
complete a perfusion experiment protocol.  
We found that stable whole-cell recordings were obtained more often from isolated green cones; 
therefore, this study was limited to this cell type only. In Figure 3.12 is shown a typical recording 
using pressure-polished pipettes, lasting more than 20 min: since the time scale is very slow, the 
waveform of photoresponses are compressed and seen as thin vertical bars. Light flashes of 
increasing intensity (ranging from 1.14·102 to 3.76·106 photons/µm2) were delivered in triplets and 
the entire sequence (with occasionally single light steps) was repeated over and over again.  
 
Figure 3.12 Typical whole-cell recording from a zebrafish cone. Upper panel: flash delivery time; lower panel, 
whole-cell recording of the current. 
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These recordings were terminated when the cone Rm, and/or its light sensitivity, decreased 
significantly. The small drift in the baseline was due to small changes in the current flowing through 
the inner segment channels rather than in changes in the light sensitive (or dark) current flowing 
through the cGMP channels. This is demonstrated by the fact that the amount of current 
suppressed by saturating flashes (with intensities ≥ 1.8·104 photons/µm2) was the same from the 
beginning to the end of these recordings (average: 18.7 ± 1.8 pA; n=25).  
To reject as much as possible the background noise, each photoresponse shown in the following 
figures is the average of three or more responses to the same flash; this average response is 
further smoothed (Figure 3.13D) by using the local smoothing routine implemented in SigmaPlot. 
This routine uses polynomial regression with weights computed from the Gaussian density 
function; the smoother function chosen as the negative exponential, with a sampling proportion 
of 0.01, a polynomial degree 1, and a number of interval that was 1/10 of the total number of 
samples constituting each trace (19220 samples for a 1 s trace). The smoothed and averaged 
responses to same flash intensities resulted very reproducible over a recording time of more than 
20 min. Indeed, consecutive flashes of same intensities delivered within ~2, ~5, ~10, and ~15 min 
from the beginning of whole-cell recording revealed no significant differences with respect to dark 
current amplitude and response kinetics (Figure 3.13A-C).  
 
 
Figure 3.13 Stability of the flash responses. (A), (B), (C), averaged and smoothed response of 3 consecutive 
flashes of same intensity delivered within ~2, ~5, ~10, ~15 min from the beginning of recording (black, green, 
red, and blue traces) of six different intensities (in photons/ µm2), grouped in two intensities in each panel: 
4.49·103 and 3.76·105 (A), 1.14·103 and 8.68·103 (B), 2.32·103 and 1.77·104 (C). (D) unsmoothed average of 
three consecutive responses to a nearly saturating flash (1.77·104 photons/µm2, black trace) is compared to 
the smoothed one (purple trace), enlarged in the inset; the flash timing is indicated in dark purple. 
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In Figure 3.14A-B-D are reported the same photoresponses that have been averaged, aligned, and 
normalized. The superimposed flash responses in Figure 3A recovered from the maximum 
amplitude in a characteristic biphasic manner, that was particularly evident for flash intensities 
ranging from 2·103 to 104 photons/µm2. This feature was observed clearly in ~40% of the 
recordings (n = 25), while other ones had a faster and monotonic recovery phase, as shown in 
Figure 3.14B (red traces, compared with the corresponding four biphasic responses of Figure 
3.14A, on an expanded time scale), or a recovery in between these two kinds (Figure 3.14B, thick 
blue trace, corresponding to the blue trace of Figure 3.14C). 
 
 
 
 
Figure 3.14 Waveform of the flash responses. (A) Flash responses of Figure 2 (A, B, and C) are averaged 
together and the corresponding six traces are aligned and normalized, other two photoresponses are added 
(flashes of 9.55·104 and 1.85·105 photons/µm2). (B) Comparison of different response waveforms resulting 
from the same flash intensities. Traces had either a prominent biphasic response (black traces: 2.32·103, 
4.49·103, 8.68·103, and 1.77·104 photons/µm2) or showed monotonic recovery (red traces; each trace is the 
average of 9-16 responses). (C) Response amplitude vs light intensity (n=25 cells, each data point is the 
average of at least 75 responses to the same flash, black dots and black line) and Hill equation fit to the data 
points with n=1, I0=2000 photons/µm2 (blue trace) and n=1.4, I0=2300 photons/µm2 (green trace). (D) Black, 
green, red, and blue traces (flashes of 1.77·104, 9.55·104, 1.85·105, and 3.76·105 photons/µm2, respectively), 
unsmoothed; yellow trace: linear fit to the rising phase of the two fastest responses (flashes of 1.85·105 and 
3.76·105 photons/µm2) having an angular coefficient of 64 s-1 (correlation coefficient: 0.97); purple trace: 
flash timing. 
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However, beside differences in the recovery phase, all green-sensitive cones had an almost 
identical response rising time and similar sensitivity, with a threshold of ~102 photons/µm2 (the 
average response to this flash intensity had always a monotonic recovery; Figure 3.13A). 
Therefore, all response amplitudes were collectively analysed as a function of the light intensity in 
Figure 3.13C.  
Data were fitted by the Hill equation: 
𝑅(𝐼) =
𝐼𝑛
𝐼𝑛 + 𝐼0
𝑛 
 
I0 is the half-saturating intenstity, which was set to 2·103 photons/µm2 in the fit giving the blue 
curve (n = 1). Changing both I0 and n to higher values (2.3·103 photons/µm2 and n = 1.4) gave a 
better fit for higher light intensities, but the fit was worse at lower intensities (green curve). 
3.8 Rising Phase Kinetics 
In order to reduce the background noise, photoresponses were averaged and further processed 
with the smoothing routine described above. This operation did not alter the entire waveform of 
the photoresponse to dim up to just saturating flashes (i.e. delivering less than ~104 photons/µm2), 
but it slightly altered the rising phase of stronger flashes at early times. Since this caused an 
underestimation of the delay between the flash delivery time and the response beginning (Figure 
3.12D), the analysis of the responses to strong flashes were performed on unfiltered traces (Figure 
3.12D; Figure 3.13D). It resulted that the rising phase kinetics accelerated by flashes up to an 
intensity of 1.85·105 photons/µm2, but above this value no further acceleration was observed 
(Figure 3.13D). The linear fit to the normalized rising phase gave an angular coefficient of 48.6 ± 
5.7 s-1 (n = 5 responses in 5 cells to flashes delivering 1.85·105 or 3.76·105 photons/µm2). 
3.9 Light Adaptation 
Characteristic features of light adaptation in single green-sensitive cones were measured by 
applying an illumination protocol as indicated in Figure 3.15A, top row. Flashes of light were 
delivered to green-sensitive cones in the absence and presence of a light adapting background. A 
step of light elicited a fast current fall, followed by a much slower recovery to a steady-state level 
as the background light stimulus remained (Figure 3.15A). The average of step response 
amplitudes became slightly smaller at the second and third step response (Figure 3.15A), because 
the intermediate time of the cell in darkness was not sufficient to reach a full recovery to the dark 
state. Despite the large amount of light absorbed by the cone, the recordings were quite stable. 
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Indeed, the waveform of the average response to three consecutive flashes delivered in the dark 
and during the step of light were almost identical at the beginning (responses under the black bars, 
Figure 3.15A; black traces, Figure 3.15B), in the middle (green) and at the end (red) of the 
recording. By comparing the average response to flashes delivered in the presence of a 
background of light with the average response to flashes delivered in the dark, we found that the 
former was smaller and faster (Figure 3.15C and D). The background of 1.3·105 photons/(µm2·s) 
suppressed 63±9% of the dark current (10 steps averaged, n=3) and reduced the sensitivity as 
follows: a flash delivering 4.89·103 photons/µm2 in the dark suppressed ~70±4% of the current 
(274 responses averaged, n=25), while a flash twice as strong delivered on the background 
suppressed ~45±12% (27 responses averaged, n=3) of the current (Figure 3.15C). Due to the extent 
of the desensitization, it was possible to compare only the response to saturating flashes delivered 
in the dark and on a background of light, as illustrated in Figure 3.15D. 
 
 
 
Figure 3.15 Stability of the light adaptation. A, lower trace, recording of the dark current; upper trace: timing 
of flashes and steps of light; the zero current corresponds to full suppression of the light-sensitive current. 
B, the average of 3 responses to the same flash (4.49·103 photons/µm2), delivered in the dark at the 
beginning (black trace and black bar in A, in the middle (green), and at the end (red) of the recording, is 
compared to the average of 3 responses to the same flash (8.68·103 photons/µm2) delivered on the 3 
identical backgrounds of light (1.3·105 photons/(µm2·sec). C, comparison between the average of the 9 flash 
responses in the dark of B (suppressing ~65% of the dark current, ~19.7 pA; blue trace), and the average of 
the 9 flash responses during the three light steps of B (suppressing ~45% of the residual dark current of each 
step, ~7.3 pA; cyan trace). D, comparison between the response to a 1.77·104 photons/µm2 flash (blue trace) 
and the response to the same flash superimposed on the same background of A in another cell (cyan trace). 
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3.10 Modulation of zGCAP3 in Single Cone Cells 
Based on the robustness and stability of the flash response and of some key features of light 
adaptation, it was concluded that the enlarged shank of the pressure-polished pipettes did not 
perturb the light-triggered enzyme cascade (i.e. it did not significantly wash out any molecule 
required for phototransduction). In order to provide insights on the role of zGCAP3 on the 
photoresponse, the effects of its cytosolic delivery or of its specific monoclonal antibody (to 
simulate the overexpression and down-regulation) were analysed according to the following 
protocol. Control photoresponses to flashes from very dim (to check the photoreceptor sensitivity) 
up to saturation (to measure the dark current amplitude) were collected over few minutes, to 
ensure that they were normal and reproducible. If not, it was usually possible to expel the cell with 
a strong pressure pulse applied to the pipette lumen, and gain the seal on another cell with the 
same pipette, by following the procedure described in Aquila et al., 2014. Once the cell healthiness 
was guaranteed, a positive pressure was applied to the pipette perfusion tube, long enough to 
expel a volume of solution containing the protein (~80 µl) that was at least three times of the 
volume of the control solution filling the patch pipette (i.e. ~25 µl).  After at least 2 minutes (to 
allow the full cytosolic protein upload, see Materials and Methods), the light stimuli protocol used 
before the protein application was repeated. 
3.10.1  Up-Regulation of zGCAP3 
It was tested first purified recombinant zGCAP3, having high sensitivity to Ca2+ in the sub-
micromolar range and strong activation of sensory GCs, being half-maximal at 30 nM free [Ca2+] 
(Fries et al., 2012). Concentrations of mammalian GCAP1 and GCAP2 have been estimated to be 
in the lower micromolar range (Hwang et al., 
2003), therefore the zGCAP3 was perfused to a 
concentration of 40 µM, that was even above the 
value of 33 µM determined in carp cones 
(Takemoto et al., 2009). However, the cytosolic 
perfusion of 40 µM of zGCAP3 (dissolved in the 
intracellular solution, see Materials and Methods) 
did not alter significantly the photoresponse 
waveform of green sensitive cones (n = 7). In only 
two cells that had an unusual small dark current 
amplitude and slow flash response waveform, the 
application of zGCAP3 produced a slight falling 
phase acceleration and an amplitude reduction of 
Figure 3.16 Effect of zGCAP3 intracellular 
delivery. Each one of the 3 traces are the 
average of 3 consecutive responses to the 
same flash (4.49·103 photons/µm2) before 
(black trace), during (dashed trace) and after 
(grey trace) the application of 40 µM of 
purified zGCAP3 (average dark current ≈ 5.7 
pA). 
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the flash response, that was substantially reversible (Figure 3.16); however, the dark current did 
not increase as the response accelerated.  
3.10.2  Down-Regulation of zGCAP3 
To perform the real-time down-regulation of zGCAP3, it was necessary first to identify a suitable 
antibody for the perfusion experiments: a monoclonal antibody named ZG3 7E6, purified by cation 
exchange chromatography, was chosen for its high specificity for zGCAP3 and lack of cross-
reaction with other GCAP isoforms. When the ZG3 7E6 antibody (6.7 µM) was perfused into the 
cytosol of zebrafish cone cells, it caused a current fall, since there was a progressive fall of 
saturating flash response amplitude, with no changes in the zero level of dark current (n = 6, Figure 
3.17A and B). Moreover, as expected by the progressively reduced Ca2+ sensitivity by GC, the flash 
response waveform progressively slowed down during the current fall (Figure 3.17B). 
 
Figure 3.17 Effect of anti-zGCAP3 (ZG3 7E6) intracellular delivery.  
A, recording of the dark current during the application of 6.7 µM of purified ZG3 7E6 dissolved in the 
intracellular solution; flashes of a 6.07·103 and 9.39·104 photons/µm2 were delivered during the current 
fall; a step of light of 1.9·107 photons/(µm2·sec) was delivered at the end of recording to check the residual 
dark current.  
B, thick traces, average of 3 non-saturating responses to a 6.07·103 photons/µm2 flash (to check the 
response waveform) delivered at the beginning of recording (black, not shown in B), at ~35 s (green), and 
at ~115 s (red). Thin traces, oversaturating responses to 9.39·104 photons/µm2 (to check the zero light-
sensitive current) at ~127 s (black, single response), ~145 s (green, 2 responses averaged), ~212 s (red, 2 
responses averaged), ~310 s (blue, 3 responses averaged), and ~332 s (magenta, 3 responses averaged); 
all responses were aligned to the zero dark current. 
  
A 
B 
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3.11 Discussion 
The data collected during whole-cell recordings from isolated zebrafish cones allow us to deeply 
investigate the mechanisms generating the light response. A peculiar feature of the recorded 
photeresponses was the fast kinetics of the rising phase at bright light intensities (Figure 3.13D), 
which reveals that within ~12 ms all the intracellular cGMP is hydrolysed. This could probably be 
due to the small volume of the cone outer segment (Pugh and Lamb, 2000) but it cannot be 
excluded that there are still less understood mechanisms that contribute to these fast kinetics. 
The frequency of interactions between rhodopsin (or cone opsin) and transducin, which diffuse 
freely on the disc membrane, has been considered a major factor in determining the slope of the 
rising phase and the cascade activation kinetics (Pugh and Lamb, 2000). Alternative studies 
suggested a different mechanism from the classical one based on collision coupling (Dell’Orco and 
Schmidt, 2008; Cangiano and Dell’Orco, 2013), suggesting that dimers of rhodopsin may interact 
with transducin in the dark by forming preassembled complexes (Dell’Orco and Koch, 2011). This 
mechanism could increase the probability of encounters between these proteins, resulting in the 
acceleration of photoresponse kinetics. 
Another interesting feature of the response waveform is the change in the recovery phase 
(monotonic vs biphasic, Figure 3.13B) recorded in different cells. A monotonic recovery was 
observed in the responses to dim flashes or supersaturating flashes, while responses to flash from 
moderate (i.e. suppressing above 20% of dark current, Figure 3.13A, B) to just saturating intensities 
produced biphasic responses. This suggests that the biphasic recovery is elicited when the 
transient Ca2+ influx suppression is significant, but at the same time, the amount of light absorbed 
by the cone is low enough to allow a rapid inactivation of the PDE, so that the cascade is quickly 
stopped. This indicates that the difference between the two recovery phases originate by a 
different intracellular Ca2+ dynamics, which in fact regulates a plethora of Ca2+ sensor proteins 
regulating the phototransduction cascade at various levels (Nakatani et al., 2002; Kawamura and 
Tachibanaki, 2008; Scholten and Koch, 2011), collectively acting as a negative feedback. 
Perfusion of zGCAP3 did not alter significantly the photoresponse; although its perfusion solution 
concentration was 40 µM, i.e. comparable or even higher in respect to its endogenous 
concentration (see Materials and Methods). Thus, lack of any zGCAP3 effect during perfusion 
suggests that the GC in double cone cells was already saturated under our measuring conditions, 
which is consistent with previous in vitro data on the half-maximal activation of GCs by zGCAP3 
being at 0.7 µM (Scholten and Koch, 2011). Further, no displacement of another zGCAP seemed 
to occur, which could have caused a disturbance of the normal photoresponse. Collectively, the 
above results indicated that zGCAP3 is probably the only relevant regulator of the endogenous GC 
in green cone cells. The rapid fall of the dark current and the progressive slowdown of the response 
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waveform observed during intracellular perfusion of zGCAP3 antibody (Figure 3.16) reveal a rapid 
shutdown of the cGMP production, consistent with an inhibition of GC. Nevertheless, the complete 
shutdown of the dark current was surprising, suggesting that the antibody can cause non-specific 
disturbances inside the small volume of the cone OS, in particular during longer perfusion.  
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Conclusions 
 
 
 
In the first project of this thesis, I investigated the mechanism of membrane perturbation of cell-
penetrating and antimicrobial peptides using the patch-clamp technique. I found that CM18-Tat11 
produces a large and irreversible plasma membrane lysis, at concentration where CM18 and Tat11 
gave instead a nearly reversible membrane permeabilization and no perturbation, respectively. 
Furthermore, using the same method, I studied the biophysical characteristic of another 
antimicrobial peptide, called CM12, which sequence was obtained from the optimization of CM18 
(Maccari et al., 2013). When applied on CHO, CM12 and CM18 produced voltage-independent 
membrane permeabilization, and no single-channel events were detected at low peptides 
concentration. These results indicate that both peptides form pores according to a toroidal model, 
in which the lipid layer bends continuously through the pore so that the core is formed by both 
lipid head groups and the peptides. Finally, I have studied the single channels properties generated 
by the pore-forming peptide alamethicin (Alm) F50/5 and its [L-Glu(OMe)7,18,19] analog. It was 
confirmed that the hydrophilic Gln residues at positions 7, 18, and 19 of alamethicin F50/5 are not 
a key factor for pore formation, but the [L-Glu(OMe)7,18,19] analogue produced larger pores, with a 
lower probability of formation than alamethicin F50/5. Moreover, the lipid-dependence of 
peptides activity was studied, comparing the single-channel recordings of the peptides applied on 
a natural membrane (frog OS) and in giant unilamellar vesicles (GUVs). Although the overall 
channel characteristics resulted comparable, both peptides generated larger events when inserted 
in GUVs. This indicates that tests on artificial membranes represent a valid starting point for the 
study of membrane-active peptide properties; nevertheless, they could not completely substitute 
the complexity of a living cell membrane.  
In the second part, I focused my attention on the role of the Ca2+ sensor and regulator of the 
guanylate cyclase zGCAP3 in mechanically isolated zebrafish green-sensitive cones. Firstly, I 
performed whole-cell patch-clamp recordings from cone cells with pressure-polished pipettes and 
found that they were stable for several minutes, having reproducible sensitivity, waveform 
photoresponse kinetics and light adaptation. In particular, we found a cell-to-cell variability in the 
flash response recovery phase, suggesting that they are governed by different intracellular Ca2+ 
dynamics. Moreover, we observed that responses to supersaturating flashes presented a very fast 
rising phase, suggesting that opsin and transducin form preassembled complexes in the dark. 
These studies were followed by experiments in which the zGCAP3 or its monoclonal antibody were 
efficiently perfused inside the cone OS by positioning perfusion tubes very close to the pipette tip. 
The up-regulation of zGCAP3 did not altered significantly the light response, while the perfusion 
71 
  
with the antibody anti-zGCAP3 caused the progressive fall of the background current, together 
with the progressive slowing down of the flash response kinetics. The surprising lack of an effect 
of zGCAP3 incorporation, suggested that the endogenous number of zGCAP3 is saturating, 
therefore any further increase of this sensor is ineffective. However, the effects of the antibody 
can be explained as an inhibition of the target enzyme of zGCAP3, which is the guanylate cyclase 
(GC).  
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